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ABSTRACT 
The dissertation mainly focuses on the excited-state photophysics and the light-
induced biological activity of hypericin and its analogs. 
Femtosecond laser technology has provided the opportunity to investigate the 
rapid dynamics of these molecules. Fluorescence upconversion measurements, which 
monitor only emission from the fluorescent singlet state, demonstrate that hexamethoxy 
hypericin, which possesses no labile protons, has an instantaneous rise time for its 
transient response. On the other hand, hypericin shows a clear 10-ps rise time. This 
confirms excited-state H-atom transfer as the primary photophysical process in hypericin. 
Femtosecond transient absorption spectroscopy technique is used to determine if 
excited state H-atom transfer is concerted. Previous studies using human serum albumin 
(HSA) and hypericin suggested that excited state H-atom transfer is concerted, but the 
results from the hypericin in reverse micelles show no evidence for a concerted hydrogen 
atom transfer mechanism. We are, however, unable to conclude if only one hydrogen 
atom is transferred or if two are transferred in a stepwise fashion. 
By means of time-resolved infrared spectroscopy, ab initio quantum mechanical 
calculations, and synthetic organic chemistry, a region in the infrared spectrum, between 
1400 and 1500 cm"1, of triplet hypericin has been found corresponding to translocation of 
the hydrogen atom between the enol and the keto oxygens, OeeeHeeeO. This result is 
discussed in the context of the photophysics of hypericin and of eventual measurements to 
observe directly the excited-state H-atom transfer. 
Light-induced antiviral activity of hypericin and hypocrellin is compared in 
normoxic and hypoxic conditions. Although both molecules require oxygen to show full 
virucidal effects, hypericin is still effective at low oxygen level where hypocrellin is not. 
Since the singlet oxygen yield of hypericin is about half of that of hypocrellin, this result 
cannot be explained by a traditional Type II mechanism. We propose that the ejected 
proton upon illumination might enhance the activity of activated oxygen species. 
A series of hypericin analogs were found to differ in their cytotoxic activity 
induced by ambient light levels. These analogs vary in their ability to partition into cells, 
to generate singlet oxygen as well as in other photophysical properties. The percent 
distribution of hypericin and its analogs in cells are measured using a steady state 
absorption technique. We attempt to find a relationship between those results and the 
exact localization of the drug at subcellular level. 
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CHAPTER 1. GENERAL INTRODUCTION 
1.1 OVERVIEW 
Due to the reliability and sophistication of laser based systems, especially ultrafast 
spectroscopic methods, we are able to study condensed-phase reaction dynamics. In 
recent years many applications of pulsed laser techniques have been developed in 
chemistry [1] and biology [2], Current laser technology provides pulses as short as 4.5 fs 
at selected wavelengths [3] and widely tunable pulses with a duration less than 8 fs [4]. 
Using this technology we have investigated the primary photoprocesses of the 
light activated antiviral and antitumor agents, hypericin and hypocrellin (figure 1.1a and 
1.1 c) In the following chapters, photophysical processes and photo bio logy of hypericin 
and hypocrellin are discussed. 
1.2 HYPERICIN AND HYPOCRELLIN 
Hypericin, 1,3,4,6,8,13 -hexahydroxy-10,11 -dimethylphenanthro [1,10,9,8-
opgra]perylene-7,14-dion (Figure la), derives its name from Hypericum, a genus of 
plants which biosynthesize the pigment and its analog pseudohypericin. Hypericin forms 
up to 0.05 % of the plant substances in some species of genus [5]. St. John's Wort 
(.Hypericum perforatum or other members of genus Hypericum) might be the richest 
hypericin source [6] and is widely distributed in Europe [7], North America, China [8] 
and the Middle East (Armenia, Jordan) [9, 10]. Hypericin extracts have been used as a 
folk medicine to treat headache, rheumatism, inflammation, wounds and diarrhea. The 
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Figure 1.1 Structures of (a) normal form of hypericin, (b) possible hypericin double 
tautomer (c) normal form of hypocrellin (d) possible hypocrellin double tautomer (e) 
stentorin. 
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structure and spectra of hypericin is closely related or nearly identical to those of the 
stentorin (Figure l.le) and blepharismin chromophores [11, 12]. There is a growing 
interest in elucidating the roles of stentorin and blepharismin in the photosensory 
transduction of Stentor coerulus [13, 14] and blepharisma japonicum [15, 16], the 
hypericin-like pigment-containing microorganisms. Song and coworkers have discovered 
light induced pH decrease across the cell membranes of S. coerulus [11]. 
A systematic study of hypericin photophysics has been carried out by Jardon and 
coworkers since 1986 [17, 18, 19, 20]. They measured the triplet quantum yield of 
hypericin to be 0.71. Futher studies have been carried out to reveal the kinetics of triplet 
hypericin [21, 22]. 
Hypocrellin derives its name from Hypocrella bambuasa, a parasitic fungus of 
Sinarudinaria sp. that grows only in southwestern region of Tibet in the People's 
Republic of China, and certain parts of Sri Lanka [23]. Like other similar perylene 
quinoids, this compound has traditionally been used as a folk medicine for many years in 
China, especially for skin lesions. 
Both hypericin and hypocrellin are peri-hydroxylated polycyclic quinones, and 
have some common chemical and biological properties. Recently, they have gained great 
interest owing to their light induced biological activities [11, 24, 25, 26]. They have 
virucidal activity against several types of enveloped viruses including human 
immunodeficiency virus (HIV) [27, 28, 29, 30], and also antiproliferative and cytotoxic 
effects on tumor cells [31, 32, 33]. Hypericin also shows an antidepressant activity [34], 
light-dependent inhibition of protein kinase C [35, 36, 37], and induces apoptosis [32, 36, 
4 
38]. 
Owing to this biological activity, we have been studying the photophysics of 
hypericin and hypocrellin [39-58]. Based on deuterium isotope effects, the study of O-
methylated analogues, and complementary studies using transient absorption and 
fluorescence upconversion techniques, we have argued that excited state hydrogen atom 
transfer is the primary photophysical mechanism in hypericin and hypocrellin in organic 
solvents. 
Hypericin and hypocrellin A acidify their surroundings upon light absorption. The 
role of photogenerated protons takes on significance in the context of the growing 
body of literature implicating changes in pH with inhibition of virus replication [59], 
antitumor activity [60], and apoptosis (programmed cell death) [61, 62]. 
1.3 PHOTODYNAMIC THERAPY 
Photodynamic therapy (PDT) is based on the dye-sensitized photooxidation of 
biological matter in the target tissue [63]. For PDT to be effective, a dye (sensitizer) 
needs to be present in the tissue. As the first step of PDT, the sensitizers are introduced 
into the organism, and are then illuminated. It is believed that some oxygenated species, 
which are harmful to cell function, are produced through various photophysical pathways, 
and finally the tissue is destroyed. 
The delivery of the photo sensitizer to the target tissue is the first step toward PDT 
tumor treatment. Bellnier et al. [64] did detailed preclinical studies of pharmacokinetics 
and tissue distribution for Photofrin II (PH) by radiolabeling sensitizers while maintaining 
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their photophysical, photochemical and biological characteristics. Most sensitizers studied 
to date do not accumulate selectively in neoplastic tissues. Some of the studies for the 
subcellular distribution of sensitizers have been done in in vitro systems. Roberts et al 
[65] found that PH initially binds to the plasma membrane, then redistributes to other 
lipophilic membrane sites, but another sensitizer mono-L-aspartyl chlorin e6 (Npe6) 
preferentially localizes in lysosomes while both are keeping PDT effects for tumor tissues. 
Based on the overview by Moan et al. [66], lipophilic, anionic dyes generally localize in 
membrane structures including plasma, nuclear membranes, mitochondria and 
endoplasmic reticulum, however hydrophilic materials accumulate in lysosomes. Certain 
cationic sensitizers can be found in mitochondria mainly due to electrical potential 
gradients across the mitochondrial membrane [67]. Research on subcellular distribution of 
hypericin also has been done by Sureau et al. [68], Vandenbogaerde et al. [37], 
Miskovsky et al. [69], and English et al. [70]. Also, in vivo studies have shown that 
although the tissue distribution pattern of hypocrellin is qualitatively similar to that of PH, 
hypocrellin shows much faster intracellular uptake kinetics [71, 72]. 
The second component for PDT tumor treatment is to deliver the light which can 
be absorbed by photo sensitizer to the target tissue. Light fluence in tissue decreases 
exponentially with the distance The effective penetration depth is inversely proportional 
to the effective attenuation coefficient (a = 1/ e «depth). The latter is influenced by the 
optical absorption due to the tissue chromophore, and optical scattering within the tissue. 
The average a is about 1-3 mm at 630 nm [73], while penetration is approximately twice 
that at 700-850 nm [74]. 
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PDT has the limitation of obtaining the proper levels of excitation light within the 
body. An interesting experiment using chemiluminescence has been done by Carpenter et 
al. [40]. They found the chemiluminescent oxidation of luciferin by the luciferase from 
the North American firefly generates the emission sufficiently intense and long lived 
enough to induce antiviral activity of hypericin. Light-induced virucidal activity of 
hypericin was shown against equine infectious anemia virus (EIAV). Some research on 
fluence rate effect in photodynamic therapy also have been carried out [75, 76, 77, 78]. 
The current study indicates that hypericin and hypocrellin have good properties for 
PDT application. They are as follows [79]: 
1) The aminated hypocrellins which have high phototoxicity and minimal dark 
cytotoxicity have a strong absorption at the phototherapeutic window range (600-
1000 nm). 
2) The compounds show the selectivity for certain tumor cell-killing in the primary tests 
both in vivo and in vitro [12, 23, 72, 80, 81, 82, 83]. 
3) Hypocrellins have a much higher clearance rate from the host body than porphyrins, 
which reduces their delayed skin photosensitivity [23, 72, 81, 82] a side effect 
involved in the PDT of porphyrins. 
4) Since hypericins and hypocrellins are different from porphyrin in structure, 
photophysics, photochemistry and biodistribution, a combination phototherapy might 
be possible, using the respective responses of hypericins/hypocrellins and porphyrins, 
to gain synergistic benifits of the different localization photophysics of the different 
photosensitiers. 
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5) Many animal and clinical experiments already have been done with both hypericin and 
hypocrellin [12, 84, 85, 86, 87]. 
Similar to ionizing radiation, the damage-inducing interactions of PDT occur 
within a very short time. Photodynamic interactions can take place wherever sensitizer, 
appropriate light and oxygen are present at the same time. A photosensitizer is first 
excited into the short-lived singlet state, then this excited singlet state photo sensitizer 
converted into the long-lived (10"3 -10 s) triplet state via an intersystem crossing (ISC) 
process. Since photosensitization usually occurs only in the triplet state, a high triplet 
yield upon light absorption is required for efficient photosensitizers. Generally it is 
believed that the triplet photosensitizers can undergo two kinds of photochemical 
reactions, i.e. Type I and Type H (figure 1.2). In Type I, the triplet photosensitizer 
directly reacts either with substrate or solvent by hydrogen atom or electron transfer to 
form radicals or radical ions, which can produce reactive oxygenated species after 
interacting with oxygen. Type I is dependent on the concentrations of the sensitizer and 
the substrate, and is favored when the sensitizer is bound to or associated with the 
substrate. In Type II, the triplet photosensitizer can transfer its energy to the ground state 
of oxygen to produce singlet oxygen ('C>2, lifetimes 4 x 10"6 s in water, 50-100 x 10"6 s in 
lipid, 0.6 x 10"6 s in cellular environment), a highly reactive, oxidative species, which can 
mediate a variety of photsensitization processes. [64, 88] It is evident that Type II is an 
oxygen dependent process. Oxygen dependence was used to distinguish Type I and Type 
II reactions. Thomas et al. [80] observed that hypericin-photoinduced cell killing was 
mediated by an oxygen dependent Type II mechanism rather than the oxygen independent 
g 
Type I mechanism. However, Fehr et al. [41] observed that hypericin is equally toxic 
against equine infectious anemia virus (EIAV) under oxygenated and hypoxic conditions. 
Type I and Type II reactions may occur simultaneously, and the ratio between the 
two processes is dependent upon the properties and concentrations of the sensitizer and 
substrate, and oxygen concentration, light intensity as well as the binding of the sensitizer 
to substrate. Several studies about this issue in the photo sensitization of hypericin and 
hypocrellin also have been done by Diwu et al. [89, 90]. Chapter 4 will discuss the 
importance of oxygen in the antiviral activity based on these mechanisms and suggest 
another possible mechanism to explain our experimental results. 
Type I 
Radicals or 
Radical ions 
} ° 2  
Oxygenated 
product(02% OH*) 
Substrate 
or solvent 
LSens 
hv 
^Sens* 
I 
3Sens*- o-
Type II 
l O ,  
Reactions 
t 
Figure 1.2. Mechanisms for photosensitized oxygenation. 
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1.4 ANTIVIRAL ACTIVITY OF HYPERICIN AND ITS ANALOGS 
The antiviral activities of hypericin and its analogs have been studied since 1988 
[27], and Carpenter et al. demonstrated that hypericin possesses light induced antiviral 
activity in 1991 [91]. There are two common features for the antiviral activities of the 
hypericin-Iike compounds. One feature is these compounds have good antiviral activity 
against enveloped viruses, but not against nonenveloped viruses [92]. The other feature is 
light enhances the virucidal activity of hypericin compounds against certain enveloped 
viruses [91, 93, 94, 95]. 
Several research results suggest that the virucidal activity of hypericin against 
enveloped viruses is different from the well-characterized antiviral nucleosides [28,96]. 
Hypericin is reported to inactivate viruses by altering viral proteins rather than nucleic 
acids [97]. It is suggested that a principal target for the light induced antiviral activity of 
hypericin-like compounds might be membranes [98, 99, 100, 101]. 
Light induced viral inactivation of hypericin against enveloped viruses is also 
attributed to the inhibition of fusion, which is a required membrane specific process for 
virus life cycle, by Lenard et al. and Stevenson et al. [28, 98]. Loss of the fusion function 
may explain why only enveloped viruses are inactivated by light activated hypericin. They 
suggest oxygen dependent Type II mechanism as a major process for the light induced 
antiviral activity of hypericin due to the resemblance of the virucidal activity between 
hypericin and rose bengal which is a good O^ photo sensitizer. However comparative 
studies for nine perylenequinones, including hypericin and hypocrellin, provide strong 
evidence that the singlet oxygen quantum yield is not sufficient to explain the reported 
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antiviral activities of these molecules and that other structural features of perylene 
quinones are involved [102]. This topic is also discussed in Chapter 6. 
1.5 DISSERTATION ORGANIZATION 
This dissertation includes five seperate journal papers (Chapter 3-7) and is 
organized as follows. 
1. Experimental apparatus including chirped pulse regenerative amplifier system, 
fluorescence upconversion system, and optical parametric amplifier (OPA) are 
described in Chapter 2. 
2. Confirming the excited state H-atom transfer in hypericin is discussed in Chapter 3. 
3. Concertedness of the excited state H-atom transfer is presented in Chapter 4. 
4. Identification of a vibrational frequency corresponding to H-atom translocation in 
hypericin is dicussed in Chapter 5. 
5. The role of oxygen in hypericin's antiviral activity against equine infectious anemia 
virus (EIAV) is presented in Chapter 6 
6. The relationship between the cytotoxic activity and the ability to cell partition and the 
singlet oxygen yields of a series of hypericin analogs is discussed in Chapter 7. 
7. General summary is described in Chapter 8. 
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CHAPTER 2. EXPERIMENTAL APPARATUS 
2.1 INTRODUCTION 
We have built several experimental systems in our laboratory for the past few years in 
order to study the excited state dynamics of biologically active molecules. Among those 
instruments the most commonly used in our lab is a time-resolved spectrometer with sub-200 
fs time resolution, based on chirped-pulse-amplification (Figure 2.1). 
Amplified 800am 1 kHz laser pulses are used to generate white light continuum as a 
probe and to be frequency doubled to make a pump pulse. We are currently building an 
optical parametric amplifier (OPA), which will give us a tunable light source. Now we only 
have 800 nm and 400 nm pump sources. 
To measure the pump-induced absorbance change, pump and white light continuum 
pulse trains at certain wavelengths are generated. White light is split into probe and reference 
beams, then both are focused through the sample. The pump beam is also focused in the 
sample and overlap the probe beam. A mechanical chopper blocks every other 1 kHz pump 
pulse before it goes through the sample. Both probe and reference go through a 
monochromator onto two silicon photodiode and OP amp assemblies. The outputs are 
measured and averaged with gated integrator and boxcar averager modules (Stanford 
Research Systems SR 250), subsequent to an analog processor module (Stanford Research 
Systems SR 235) where the probe signal is divided by the reference to provide a shot-to shot 
normalization to eliminate the effect of probe pulse intensity fluctuations. The natural log of 
the quotient is calculated in the module, and sent to a third boxcar averager, which is 
operated in toggle mode to do an active baseline subtraction. AA is calculated using the 
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Figure 2.1 Schematic of the time-resolved absorption spectrometer. MC: monochromaton, 
PD: photodiode, WP: wave plate, TFP: thin film polarizer, BS: beam splitter, HR: high 
reflector 
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difference between the probe/reference ratio when the pump is blocked and unblocked by 
chopper. Then averaged outputs are converted to digital signal in the AZD board, and sent to a 
personal computer. The change in absorbance is measured as a function of delay time 
between the pump and probe pulses and the probe wavelength. 
2.2 REGENERATIVE CHIRPED PULSE AMPLIFIER SYSTEM 
2.2.1 OVERVIEW 
The recent progress in femtosecond laser technology has had a great impact on 
science and technology. Currently, the most widespread and convenient means to generate 
high intensity ultrashort pulses is by means of a technique called Chirped Pulse 
Amplification (CPA) [1], CPA of femtosecond pulses using a Tizsapphire laser was first 
demonstrated by Squier et al. [2]. 
Figure 2.2 shows a schematic of the Ti: sapphire chirped pulse amplifier system. 
Millennia V Diode pumped cw laser pumps a Tizsapphire oscillator, and the output of the 
oscillator is a 100 MHz pulse train which has —50 fs pulse duration and 2-4 nJ energy/pulse 
at 800 nm. Before going to the amplifier, these pulses are stretched to ~200 ps in the pulse 
stretcher to increase the pulse duration -4,000 times, which reduces the peak intensity, so 
that they may be amplified without damaging the amplifier optics. Then, the stretched pulses 
are sent to a Tizsapphire regenerative amplifier, which is pumped by a NdzYLF laser firing at 
1 kHz. The amplified pulse energy is —800 gJ. The amplified pulses are sent to a pulse 
compressor to restore the pulses to the pulse duration of 150 fs with the final energy of—450 
pj. Another instrument to protect our amplifier system is a missing pulse detector, which is 
an electronic timing circuit that checks for missing pulses in the synchronization pulse train. 
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A detailed description of the construction and operation procedure for CPA (Chirped Pulse 
Amplification) is given elsewhere [3] Here some important additional information and 
modifications of the system are described. 
2.2.2 MILLENNIA V 
Spectra physics Millennia V Diode-pumped cw visible laser is the pump source for 
our Ti: sapphire oscillator. It provides greater than 5 W of532 nm output from a standard 
110 or 220 Vac, single phase outlet. The laser offers beam quality, beam pointing and 
amplitude stability that are equal to or better than that of a conventional small frame ion 
laser. In addition, the optical noise is more than an order of magnitude lower than that of a 
comparable ion laser. This laser uses the neodymium yttrium vanadate (NdzYVO*) as a gain 
medium, and the lithium triborate (LBO) nonlinear crystal for the frequency doubling. The 
temperature of the NdzYVO* crystal in the laser head is controlled by the compact 
recirculating chiller. The temperature is set at 18 °C to give an optimum performance. 
Because the Millenia V is a closed-loop system, it requires no facility water connections. 
Steamed distilled water should be used for the chiller. The noise level of the output power 
was measured less than 0.05 % rms. The output of the laser is vertically polarized to the 
table. By using a periscope the polarization has been rotated to horizontal and the beam goes 
to the Tizsapphire oscillator. 
2.2.3 TI: SAPPHIRE OSCILLATOR 
After being developed by Spence et al [4], the self modelocked Tizsapphire laser has 
been the principal workhorse in ultrafast science. This work is based on Kerr-lens 
modelocking (KLM) mechanism which uses self-focusing in the gain medium. For the laser 
material, the refractive index is given by n = no + n2 /, where I is the optical intensity, and 
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Figure 2.2 Schematic of the Ti: sapphire chirped pulse amplifier system. Solid arrows 
represent the paths of laser beams, and dashed arrows represent electronic connections. The 
pump laser for the oscillator is not shown. 
is the nonlinear refractive index [5, 6], Optical Kerr effect adds a nonlinear intensity 
dependent delay to the linear contribution because the phase delay experienced by the 
propagating optical signal is proportional to the index of refraction. The intensity of a 
Gaussian pulse varies across both its temporal and its spatial profile, so different parts of the 
profile will experience a different index of refraction. As a result, an index profile in the 
material, which is similar to that of a positive lens, will be produced, and this makes the 
beam focus itself (i.e. Kerr Lensing). Pulse shaping as well as pulse profile modulation by 
optical Kerr effect is continued until the pulse is compressed to its final steady-state value. 
Self-modelocking is achieved by these effects of self-phase-modulation (SPM) [7, 8], and 
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self-focusing. SPM occurs in the temporal domain. For a Gaussian pulse, the more intense 
center of the pulse experiences a higher index of refraction than the wings of the pulse, 
therefore there will be a phase change across the pulse profile during propagation. So, SPM 
produces a "chirp," that is, the pulse develops a frequency sweep across itself because the 
derivative of phase with respect to time is equivalent to a frequency change. 
The design of our self modelocked Tizsapphire laser was first developed by Asaki et 
al [9]. This system is rather stable on daily bases. Stable room temperature is very important 
for the oscillator, so by experience a couple of hours of warm up time is needed before 
getting a stable modelocking. Also, the power supply of the other pump laser, which might 
generate heat, should be turned on to avoid subsequent temperature changes. There is no 
need for even minor adjustment for more than a week when everything is optimized and the 
temperature is stable. However, if the laser should become badly misaligned, it is usually 
necessary to realign the system "from scratch," using the following procedure. 
1) Start from the short cavity indicated in Figure 2.3 : curved mirrors Ml and M2, the output 
coupler (OC), and the high reflector (HR). 
a) Make the pump beam level along the center of the rail at 4" beam height. Make sure the 
pump beam goes through the center of Ml. The Ml mount has —10° angle with respect to 
normal. Make the position of M2 similar to that of Ml and check if the beam hits the 
center of the mirror. 
b) Put the OC and HR close to Ml and M2. Pump at 5 W and try to get lasing by 
overlapping the fluorescence spots. Place a white card right in front of OC, and you will 
see a © image on the card if you put a red filter and block the green, then overlap the 
center of this image with the reflected image from HR. Once you got a good overlap on 
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Figure 2.3. Short cavity of the Tizsapphire oscillator. Ml, M2z curved mirrors 
Lz lens, OCz output coupler, HRz high reflector 
the OC, put the white card in front of the HR and make overlap again. If you do not 
obtain lasing, change the distance between Ml and M2. By translating either Ml or M2 
or both you may see a brief flash of light. Set their position there, 
and optimize the power by alternatively tweaking vertical and horizontal knobs on the 
OC and HR, and translating the lens and curved mirrors. 
2) Extend the cavity length. See Fig 2.4. 
Replace OC with mirror 3 (M3) and rotate M3 to make reflected green beam parallel to 
the beam traveling between Ml and M2. Put OC close to M3. Put a white card which has 
a hole in it between M2 and M3, and overlap the incoming and reflected fluorescence 
from the OC to get lasing. To see this clearly use orange goggles and place the red filter 
between M2 and M3. If you don't get lasing after everything overlaps perfectly, move 
Ml forward to move the focus back. If you see lasing now, set the position there and 
optimize the power again. You should be able to obtain ~1 W of continuous wave lasing 
action at 5 W pump power. Extend the OC to the desired total length and optimize the 
power. Now move the HR back until it reaches the desired length, a distance from Ml 
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Figure 2.4. Short cavity of the Tizsapphire oscillator. Ml, M2z curved mirrors 
M3z Mirror Lz lens, OCz output coupler, HRz high reflector 
roughly equivalent to its distance from Ml when the prisms are present, and maximize 
the power by tweaking horizontal and vertical controls on the HR and OC, and translating 
the curved mirrors, mainly M2. 
b) Insert the first prism by grazing a bit of the Tizsapphire laser beam off the apex of the 
prism, and rotate it until you see minimum deviation of this light. Insert the second prism 
into this beam, and find minimum deviation position. 
Place another high reflector after the second prism, and retroreflect this beam. Translate 
the prism into the beam until the laser is barely lasing, and optimize the power by moving 
M2 forward and tweaking the HR close to the second prism. Move the prism completely 
into the beam and optimize the power again. You should be able to obtain -600 mW at 5 
W pump power. See figure 2.5. 
3) To obtain modelocking, first move out prism 1 until the power starts to drop while 
measuring the output lasing power. Repeat this for the prism 2. This way continuous 
wave lasing (cw) is suppressed and the modelocking mode is sustained. Then simply by 
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translating Ml or M2 towards the crystal by hand, and letting it back onto its original 
position is sufficient to establish modelocking. Sometimes slowly translating M2 forward 
after translating it back some distance needs to be accompanied with the action above. 
The modelocking procedure is also given elsewhere [3]. 
2.2.4 CHIRPED PULSE AMPLIFICATION 
Regenerative Amplifiers permit maximum energy ejection using a relatively simple 
cavity design. They are very well suited for seeding with low energy pulses. Having 
generated the short seed pulse, we need to be careful about the amplifier design. 
Nd:YVO 4 532 run CW 
Ti:Sapphire Rod 
OC M3. ! 
800 nm 
600 mW 
j HR 
Figure 2.5. Full cavity of the Tizsapphire oscillator. Ml, M2: curved mirrors 
M3: Mirror L: lens, OC: output coupler, HR: high reflector, PI, P2: glass 
LAKL21 prisms 
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Although the nonlinear refractive index and the resulting self-focussing is useful for short 
pulse generation in the Tizsapphire laser oscillator, they must be avoided in the amplification 
process. At very high pulse intensity, there is the possibility of the pulse distortion in the 
temporal and spatial domains. In amplification there is therefore a high risk of damaging the 
amplifier optics and gain medium when self-focusing is increased to a certain level. Hence, 
first we need to stretch the pulse duration by several orders of magnitude to reduce the peak 
pulse intensity. We then amplify the pulse. The pulse is subsequently compressed in the 
temporal domain. 
2.2.4a Optical isolator 
To avoid the amplified pulse following the reverse path of the seed pulse going back 
to the oscillator and disrupting the modelocking, we need a means to separate the incoming 
and outgoing pulses. This can be achieved by using an optical isolator, which is the 
combination of a thin film polarizer, a half wave plate, and a Faraday rotator. The 
schematic of the optical isolator is shown in Figure 2.6. 
The Faraday rotator consists of a nonlinear magnetooptic material (such as yttrium-
iron-garnet or terbium-garnet) [10] within a cylindrical ferromagnet. The Faraday rotator 
rotates the polrization of the linearly polarized beam, with a direction of rotation which 
depends on the magnetic field direction but not on the direction of travel of the beam. When 
a linearly polarized beam passes through the Faraday rotator, its polarization rotates by a 
certain angle a which depends on the medium length. And when it comes back, this beam 
obtains an additional rotation through an angle a, making a total rotation of 2a. Horizontally 
polarized laser pulses from the Tizsapphire oscillator pass through the thin film polarizer, 
which transmits horizontal (p-polarized) beams and reflects vertical (s-polarized) beams, and 
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half wave plate, and then through a Faraday rotator (a=X/4) which preserves the polarization. 
The pulses chirped by the stretcher come back along the same path, and the Faraday rotator 
and half waveplate combination rotates the polarization from horizontal (p-polarized) to 
vertical (s-polarized), so the outgoing pulses are reflected by the thin film polarizer. Then, 
the vertically polarized chirped pulses are sent to the regenerative amplifier, passing through 
a 95% reflecting beam splitter. Since the grating has poor diffraction efficiency for vertical 
polarization, the 5% of the amplified pulse that comes back along this pass can be effectively 
filtered by the stretcher. 
2.2.4b Pulse Stretcher 
Although the energy of the pulses out of the Ti: sapphire oscillator is very low, due to 
the short pulse width, the peak powers of the pulses are high enough to give catastrophic 
damage to the optics of the regenerative amplifier. This can be avoided by introducing a 
chirp to the seed pulses by a pulse stretcher. Using our pulse stretcher (Figure 2.7), the pulse 
duration is increased (and the peak power is also reduced) by -4,000 times. 
From 
oscillât 
Out to Regen. Amplifier 
Faraday Rotator 
To and from 
stretcher 
Figure 2.6 Schematic of the optical isolator. TFP: thin film polarizer, WP: wave plate 
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Dispersive elements like diffraction gratings or prisms can introduce a chirp by 
sending different wavelength or frequency components along different paths. The 
frequencies are separated by four dispersive elements, travel different path lengths, and are 
reunited collinearly. In this design each pulse makes four passes through the stretcher. The 
beam goes into the stretcher by passing above M3 and hits grating Gl. The dispersed beam 
travels to a concave mirror Ml, which is 0.5 m from Gl, and then collimated. The concave 
mirror is used because it is achromatic, and unlike a lens it does not add material group 
velocity. The collimated beam goes little bit downward to M2, is retroreflected toward Ml, 
continues back to Gl, and then finally arrives at M3. The retroreflected beam from M3 is 
sent backwards along the original path, hitting the grating Gl two more times for a total of 
four. 
Ml M2 
normal 
Gl 
M3 
Figure 2.7 Optical schematic of the pulse stretcher. Gl : 2000 g/mm gold coated grating, 
blazed for the near infrared, Ml: silver coated curved mirror, r=0.5m, M2, M3: gold coated 
flat mirrors 6: an angle of incidence The beam from the isolator goes above mirror M3, 
parallel to the table and in the plane of diffraction. The dispersed beam propagates downward 
onto M2 via Ml and reflects back toward Ml, then continues back to Gl and finally M3, 
which retroreflects the beam back along its original path, striking the grating total of four 
times. 
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2.2.4c Nd:YLF Laser 
The pump source of our regenerative amplifier is a model 527DP-H 105CM NdrYLF 
Laser. This Q-switched laser uses an intracavity LBO crystal to generate second harmonic at 
527nm.A current of about 33 A is sufficient to produce 15mJ pulses at 1 kHz, and the pulse 
duration is about 150 ns. The peak power instability is 4% p-p. 
2.2.4d Tizsapphire Regenerative Amplifier 
The typical pulse energy emitted from a KLM oscillator is if the order of a few 
nanojoules (10"* J), but this can be increased up to the Joule level in a series of amplifier 
stages. The use of regenerative amplification for short pulses has been demonstrated by Barty 
et al. [11], and Zhou et al. [12a, 12b]. Our amplifier cavity (Figure 2.8) is based on the 
design given by Squier et al. [13]. 
The seed pulse is injected into a laser cavity, allowed to make multiple passes through 
the amplifier medium, and then the amplified pulse is ejected. This regenerative system is 
very efficient because it is possible to trap the pulse in the amplifier until the gain saturates, 
thus ejecting all the available energy. To inject a weak pulse into the cavity, and to eject that 
pulse from the cavity after amplification, it is necessary to introduce an optical switch, which 
can quickly turn the beam polarization, together with a polarization sensitive element into the 
cavity. The s-polarized seed pulse is injected by reflecting the beam off an intracavity thin 
film polarizer, and a Pockels cell is used to rotate the polarization by 90° (p-polarized), so the 
pulse is kept in the cavity. The Pockels cell is an electro-optic crystal (KD2PO4) whose 
birefringence can be changed by applying a DC electric field. The Pockels cell assembly 
(Medox Electro-Optics) includes electronics which can switch ~3 kV across the crystal in ~4 
ns to produce the electric field. Once the pulse has been amplified to the required level, the 
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Figure 2.8 Diagram of the chirped pulse regenerative amplifier. HR: high reflector, TFP: thin 
film polarizer, BS: beam splitter, WP: wave plate, L:lens, FPD: fast photodiode. The seed 
pulse train and amplified pulse train enter and exit off of the same thin film polarizer. A 
pockels cell is used to switch pulses into and out of the amplifier cavity. A fast photodiode 
(FPD) placed at the flat high reflector monitors the growth of pulse energy. 
beam polarization is again rotated 90° (s-polarized) by the Pockels cell, and the pulse is 
reflected by the thin film polarizer and ejected from the cavity. 
A timing signal (must be >0.4 V) from the fast photodiode monitoring the oscillator is 
divided to produce a 1 kHz synchronized clock. The Q-switch of the Nd: YLF laser is 
activated upon this external "sync out" trigger, which is from the Pockels cell driver, and 
about 3.5JJ.S later, the 527nm Nd:YLF laser pulse creates a population 
inversion in the Ti: sapphire rod. By first applying high voltage using "delay one" of the 
Pockels cell, which is set to follow the pump laser pulse by 200 ns, the pulse is trapped in the 
cavity and will be amplified. After 5-6 round trips, the gain begins to saturate. After that, the 
pulse energy begins to diminish, rather than increase, with each round trip. "Delay two," 
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triggered by "delay one" is adjusted to eject the pulse when pulse build up is optimum, so 
maximum output energy is produced. 
A missing pulse detector (MPD) is added to this amplifier. This, an electronic timing 
circuit, checks for missing pulses in the syncronization pulse train. So, when the oscillator 
and its synchronization signal become unstable, the whole amplifier system including 
Pockels cell and pump laser will be shut down. MPD prevents erratic Q- switching of the 
pump laser and the amplifier cavity, therefore it keeps the optical components such as the 
doubling crystal in the Nd: YLF laser and the Pockels cell safe. 
2.2.4e Pulse Compressor 
After being ejected from the amplifier cavity, the amplified pulse is sent to the 
compressor, and the chirp of the amplified pulse is removed after passing through the dual 
grating system twice, resulting in a short and high energy pulse which is near transform 
limited [14]. Figure 2.9 shows the layout of the pulse compressor. 
2.3 OPTICAL PARAMETRIC AMPLIFIERS 
2.3.1 BACKGROUND 
The main purpose of optical parametric amplification is to generate frequency tunable 
ultrashort light pulses, so it can be a very good alternative to dye amplification. In 
a suitable nonlinear material, if a strong pump light wave is incident at frequency ©3, by 
parametric amplification and generation, the amplification and generation of two lower 
frequency light waves at frequencies ©1 and ©2 are observed. There is a relation between the 
pump and other generated or amplified waves. 
0)3 = CO2+ oil (0)3: pump frequency, 02: signal frequency, ce>i: idler frequency) (2-1) 
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Ml 
G2 
normal 
From amplifier M2 
Gl output 
Figure 2.9 Diagram of pulse compressor. Gl, G2: 2000 grooves/mm, gold coated grating, 
Ml, M2: mirror, 0: an angle of incidence. The gratings are oriented with their feces parallel 
with angles of incidence and diffraction nearly the same as of that in the stretcher. The 
incoming beam from the amplifier, which is coming above M2, is diffracted at Gl, 
collimated off of the second grating, and reflected back with Ml. The reflected beam from 
Ml is vertically off so that it can be picked off with M2. The separation between two gratings 
can be adjusted by translating the Gl along the main axis. 
This relation can be considered as the energy conservation equation. The efficiency of this 
conversion is very high when the phase matching condition between frequencies ©2, ©1 and 
the pump frequency ©3 is satisfied. 
Ak = *(©3) - *(©2) - /r(©i) =0 (Ai is the wavevector of each field) (2-2) 
In the case of collinear interaction, this reduces to the scalar relation 
Ak = #(©3) - *(©2) - *(©1) = 0 (2-3) 
The term "parametric process" is based on a periodic change of a parameter of a 
resonant circuit, usually of the capacity of the circuit [15]. Certain frequencies related to the 
changes of the system parameters are generated and amplified in this way. The nonlinear 
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crystal works as the circuit in optical parametric amplification, and the susceptibility of the 
nonlinear crystal can be changed with the radiated frequency by a strong pump wave. 
When the intense pump wave 0)3 and a signal wave ©2 interact with a nonlinear 
crystal, this system works as a parametric amplifier, and during the amplification process a 
third wave which has a frequency ©1 is produced. This third wave is called the idler wave, 
and has the wave number vector *(©1) = £(ro3) - £(©2). The parametric process can also occur 
without the signal input when a very intense pump wave is applied, this is because the photon 
noise can act as a signal, and the amplifier works as a generator. Although unseeded optical 
parametric amplifiers (OPA's) have broad tunability and efficient energy conversion of the 
pump into a signal wave, the amplified pulse width is limited to that of the pump pulse [16]. 
However, by compression of the pulse after the continuum amplification, dye amplifiers 
successfully produced pulses as short as 6 fs [17]. 
The frequencies ©2, ©1 are determined by the phase matching condition and the 
interaction geometry. The tuning of the frequencies is achieved by changing the effective 
refractive indices in the nonlinear crystal by either rotating the crystal or altering its 
temperature. 
OPA systems can be pumped by both the fundamental [18,19, 20], and the second 
harmonic [21, 22,23] of amplified Ti: sapphire lasers. If one pumps with the fundamental, 
owing to higher pump energies and smaller group-velocity mismatches, one obtains higher 
energies; however, the blue tuning limit for this system is only 1.1-1.2 pm due to the 
absorption of the idler in the nonlinear crystal. Thus although frequency doubling can be 
done for the output of a fundamental pumped OPA, one loses a substantial part of the visible 
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spectrum. On the other hand, tunability into the blue-green can be achieved by pumping with 
the second harmonic of the Tizsapphire laser system. 
Two main advantages of optical parametric processes to amplify femtosecond pulses 
are high gain and broad amplification bandwidth. The intensity gain coefficient g is given by 
[24]. 
g = (T2-(A*/2)2)I/2, (2-4) 
r2= 2 CQsCOj I fikfr 12=  8 7t2 UrfrPQ 
Go n$ n, iip c Go n$ n% Up c (2—5) 
&k = k2 + k\ — kz (2-6) 
where n^Q is the index of refraction of the signal (idler) wave, (%(,) = 2TTCA. SCD, <t> is the pump 
intensity, Go is the permittivity of the free space, 8.85x10"12 C2 s2 /kg m3,_*/eff is the effective 
nonlinear coefficient of the crystal, for type II phase matching in BBO, </cff=d22 cos2 6, [25] 
with d%2=2.2 pm/V [26], for type I phase matching dcs= d^sinB - dzz cos9 [27] with d3i=± 
(0.07±0.03) d22 [28]. 
If there is any nonzero phase mismatch Ak, it will suppress the gain. When Ak is zero, 
the gain coefficient is only proportional to the square root of the pump intensity. So 
increasing gain coefficient has some limitation because the pump intensity is limited by 
the onset of self focusing, which results in continuum generation. 
In general, there are two types of phase matching called type I (or parallel) and type II 
(or orthogonal) phase matching. The polarization vectors of the generated waves at ©i and toz 
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are parallel (and orthogonal to that of the pump at (03) in type I phase matching, whereas in 
the type H process the polarization vectors at <01 and ©2 are perpendicular (with the pump 
polarization parallel to one of the generated waves) To satisfy the phase matching condition, 
the birefringence in the nonlinear optical crystal can be used. In uniaxial biréfringent crystals 
the refractive index We(0, GO) for the wave of extraordinary polarization, which propagates at 
an angle 6 to the optical crystal axis, is given by 
1 cos2 0 sin2 0 
"
e(0, to)2 [w°(©)]2 + K(m)]2 (2-7) 
where ne(co) is the refractive index of an extraordinary wave, which propagates 
perpendicularly to the optical crystal axis. The phase matching angle for sum or difference 
frequency miring can be calculated from 
©3 »%0, ©3) = ©2 "°(û>2) + ©i w°(©i) (2-8) 
for type I phase matching, 
©3 «c(0, ©3) = ©2 «"(©2) + ©i ne (0, ©i) (2-9) 
for type II phase matching. 
2.3.1a Walk-off effects 
In addition to phase mismatch, spatial and temporal walk-off play an important role in 
the operation of parametric devices. Although the phase-matching condition is perfectly met, 
the maximum useful interaction length can be severely limited by walk-off effects, thus 
resulting in serious degradation in the nonlinear gain. This is from the reduction in the spatial 
or temporal overlap of the interacting beams like pump and signal with propagation through 
the nonlinear medium. 
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Spatial walk off arises from crystal double-refraction. In biréfringent anisotropic 
material, the direction of the energy flow or the beam direction is not same as the direction of 
the wave-normal or the ^-vector, which means that in a collinearly phase-matched 
interaction, though the £-vector of the interacting waves are in the same direction, the 
corresponding rays walk off from one another while propagating through the medium. This 
reduces the energy interchange between the pump and the generated field while propagating 
through the medium. So, after traveling a finite distance through the medium, the nonlinear 
interaction can become ineffective. In the presence of spatial walk-off, the maximum useful 
crystal length is limited by this distance, which is given by [29] 
P (2-10) 
where too is the input beam waist radius, and p is the double refraction angle. So, by using 
large beam waists and small double refraction angle, the walk-off effect can be minimized. 
However, small double refraction angle, which is a consequence of birefringence, is not 
always desirable because it can restrain phase matching. By applying noncritical phase-
matching geometries where the beams transmit along one of the principal index axes of the 
crystal, spatial walk-off effects can be removed. The crystal does not show double—refraction 
in these directions, so the wave-normal and beam directions become coincident and /a 
becomes infinite. The nonlinear interaction is thus maximized, and high nonlinear gain can 
be achieved by using tightly focused beams and long interaction lengths. Other techniques 
for minimizing walk-off are the use of cylindrical focusing in the plane of walk-off [30], 
optimal mode-matching [31], and non-co 11 inear interaction [32]. 
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Temporal walk-off as well as spatial walk-off can give a strong influence on three 
wave interactions and reduce nonlinear gain by limiting the useful interaction length. This is 
important especially in the ultrafast regime where femtosecond and picosecond pulses are 
involved. When such pulses propagates in dispersive media, usually group velocities are used 
to describe the interaction because this is the speed of pulse envelope (or the pulse energy) in 
the medium. The group velocity mismatch between the interacting pulses induces temporal 
walk-off, which results in the reduced nonlinear coupling and energy transfer between the 
pump and parametric pulses while propagating through the crystal. Temporal walk-off can be 
described by pulse-splitting length, the distance after which they separate by a path equal to 
their pulse width, and is given by 
1 1 ^ _1 
of ~ ÔJ (2-11) 
where Ax is the full-width at half-maximum pulse width, and ug is the group velocity. From 
this equation temporal-walk-off is getting increased with shorter pulse duration and larger 
group velocity mismatch. Group velocity is defined by 
dco c c -v, 
,g=.— — f . . on 
/?2 = AT 
• t C u*=  =  l+X dk n I dX J (2-12) 
where n is index of refraction, Œ is 2 7tf =2 TIC/ X. 
Then, group velocity mismatch is given by 
1 
AuB Au2„: 
1 1 ^ 
u2 ui (2-13) 
Temporal walk-off can be reduced by using materials with small group velocity mismatch or 
by employing noncollinear geometries [33] 
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2.3.1b Material requirements 
The choice of the nonlinear crystal is critical in the design of parametric devices. The 
main criteria for the nonlinear crystal are broad tunabilhy range, large effective nonlinear 
coefficient for efficient conversion, and high optical damage tolerance which is most 
important. Based on equation 2-5, parametric gain is dependent on the input pump intensity, 
O. At the higher input intensity the larger nonlinear gain and the stronger parametric 
interaction can be achieved. If the material damage threshold is too low, although all other 
design criteria is satisfied, parametric generation will be suppressed by the onset of damage 
and threshold will not be reached. The crystal (3—BaBiC^ (BBO) meets all these condition. 
Most OPA systems are employing type I phase matching for the nonlinear crystal. Although 
type I phase matching has a higher nonlinear coefficient, all type I crystals have a problem of 
exploding bandwidth as approaching to degeneracy (when cos = Qj)- However type II phase 
matching does not have that problem. The parametric gain band width can be estimated by 
use of the following formula [16]. 
where L is the length of the crystal, c is the speed of light, and u^d is the group velocity of 
the signal(idler). Fo is related to the parametric gain, and defined in equation 2-5. The index 
of refraction is calculated based on the Sellmeier equation using parameters given by Kato 
0.53 
(2-14) 
[25] 
rà = 2.7359 + 
0.01878 
- 0.01354 X2 
X2-0.01822 (2-15) 
n| = 2.3753 + Q-01224 0.01516 X2 
X2-0.01667 (2-16) 
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where X is in microns. 
In type I phase matching (e —> o +o), both signal and idler have same polarization, so 
since group velocity mismatch goes to zero as the wavelengths approach to degeneracy, there 
is a bandwidth explosion problem (Figure 2.10). 
In type II phase matching (e —» o +e), the polarization of the signal is perpendicular 
to that of the idler, so group velocities are not the same even at degeneracy. The bandwidth 
for type H phase matching is narrower than for type I at all wavelengths. 
The bandwidth for type II phase matching remains essentially flat from 500nm to 
degeneracy (Figure 2.11). The calculated group velocity mismatch between pump (412nm) 
and signal waves for type II phase matching based on eq. 2-12 and 2-13 is in figure 2.12. 
T 1200 
0 
1 800 
> 
I 400 
CD 
600 500 700 800 
Wavelength (nm) 
Figure 2.10 Calculated bandwidths based on eq. 2-14 for type I phase matching in a BBO 
crystal. Actual parameters are O = 140 GW/ cm2, L = 3 mm Pumped at 412nm. 6 is at 27.6°. 
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Figure 2.11 The calculated bandwidths for the first stage OPA (type H BBO). The 
experimental parameters are <X> = 140 GW/ cm2, L = 3 mm. Pumped at 412nm. 6 is at 
32°. 
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Figure 2.12 Group velocity mismatch between pump (412nm) and signal waves for type II 
phase matching in a BBO crystal. 
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2.3.2 NONCOLLINEAR PARAMETRIC AMPLIFICATION 
Optical parametric generation and optical parametric amplification are widely used 
for giving tunable intense light sources. Some of the common nonlinear crystals such as 
BBO, LBO, and LiI03 have the interesting birefringence and dispersion properties, which 
allow phase matching between pump beam wave vectors and the signal (idler) wave vectors 
to be achieved for collinear as well as for noncollinear propagation directions. For the 
picosecond or nanosecond pulses, usually the efficiency of the collinear parametric process is 
higher than that of the noncollinear process. This higher efficiency occurs because parallel 
beams have the longer overlapping interaction length of pump and parametric waves inside 
the crystal than the beams crossing at an angle. So, for picosecond and nanosecond pulses, 
efficient conversion of the pump energy into signal and idler can be achieved in long 
nonlinear crystals. 
When high intensity ultrashort pump pulses were employed, high efficiency was 
observed for both collinear and noncollinear parametric processes [34, 35,36] This is 
because high parametric gain can be achieved by strong femtosecond pulses in nonlinear 
crystal within a few millimeters which is relatively short interaction length And also when 
the phase matching condition as well as the group velocity matching condition are met, the 
highest conversion can be achieved. The group velocity matching becomes very important 
when nonlinear crystals have large dispersion, pulse duration is very short like tens of 
femtosecond, and pump pulse wavelengths are in UV spectral ranges (shorter than 400-500 
nm) [46, 47]. In this case noncollinear parametric process is more efficient. 
An interesting property of P-barium borate (BBO) was found in optical parametric 
generation [37, 38,39]. When using nonlinear phase matching, the angle between a pump 
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and signal is set to be around 3.7°, the phase matching angle becomes independent of 
wavelength over most of the visible, so very large gain bandwidths can be achieved. And 
also there is another factor to provide high gain. There is an angle (4°) that spatial walk-off 
between pump and signal is compensated, and this angle is very close to the angle described 
above. Recently broad band OP A's seeded by the white light continuum were built based on 
this concept and those were tunable across the visible [40, 41]. Amplified pulses with a 
FWHM band width extending from 790nm to 535nm, and pulse duration as short as 8 fs have 
been reported. 
The use of noncollinear amplification appears to be necessary if one wants to run the 
OPA with very short pump pulses (like a few tens of femtoseconds), or in the UV spectral 
range, where large collinear group velocity mismatch occurs. For our experiment we built a 
collinear optical parametric amplifier because this collinear approach is simpler and gives 
efficient amplification with the 1806, 400nm pump pulse. Also, spectral resolution is more 
important than temporal resolution for our case. 
2.3.3 DESIGN AND OPERATION 
Our OPA system employs the two-stage configuration based on the design of 
Greenfield et al. [42] (Figure 2. 13). The pulse energy out of the amplified Ti: sapphire pulse 
is -480 (jJ/pulse following compression. The preamplifier stage uses a 3-mm long BBO type 
11 crystal, which is cut at 0 = 32°. For the amplifier stage the 2mm type I BBO crystal, which 
is cut at 6 = 27.6° is employed. The tuning range of the OPA only depends on the first stage. 
Five percent of the recompressed beam is split off using a beam splitter to generate 
white light. Its intensity is adjusted by a half waveplate and a thin film polarizer combination, 
and the pulses are focused with a 150 mm f.l. lens into a 3 mm thick sapphire disk. A stable 
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white light continuum generation is obtained by carefully adjusting the intensity of the pump 
beam to slightly above threshold, which results in less than 5% continuum intensity 
fluctuations. The polarization is rotated into the horizontal plane by a half-wave plate to 
match the signal polarization. The remaining fundamental is eliminated by using an 800-nm 
low-pass filter. This white light pulse is used to seed a two stage optical parametric amplifier 
(OPA). The beam waist of the remaining intense 800 nm pulse is reduced to 1 mm by using a 
3x telescope, and the reduced beam goes into a 2-mm long type I lithium triborate (LBO) 
crystal and provides 100 pJ pulses at 400 nm. The blue is then split using a half waveplate 
5% BS 406 nm 
2 mm LBO-I HWP 
HWP 
HWP 
0Û Y\ 
HWP, 
Continuum 
Seed 
4 
2x 
Tunable output 
475nm-820 nm 
2-3 pJ, < 190 fs 
$ 
idler 
co. 
z2_ 
Signal 
co. 
i 
DBS 3mm BBO-H DBS 2mm BBO-I DBS 
Figure 2.13 Schematic of the OPA. This design was taken from Greenfield [42]. HWP: half-
wave plates, BS: beam splitter, TFP: thin-film polarizer, DBS: dichroic beam splitter, IF: 
800-nm low pass filter, LI: lens, 150mm, L2: lens, Ç> = 25mm, SP: sapphire plate, BBO-
I, BBO-H, Type I and Type II phase matching crystals, respectively 
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and a thin film polarizer combination, with approximately 20 diverted to pump the 
preamplifier stage of the OPA. The white light continuum is focused with 25 mm f.l. lens 
into a 3 mm type II p-Barium Borate (BBO) crystal, and the blue light is reduced with a 3x 
telescope, and combined with white light continuum seed by a dichroic beam splitter. Spot 
sizes for the seed and the pump beams are 1.4 mm and 0.45 mm at the first crystal. The pump 
intensity is 70 GW/cm2 (You can see weak off -axis parametric superfluorescence at this 
intensity). The amplified output energy out of the first stage is —300 nJ (both signal and 
idler). By carefully adjusting a variable delay line and direction of the beams, spatial and 
temporal overlap of the beams is achieved. 
The blue light transmitted through the thin film polarizer is used to pump the 
amplifier stage after changing the polarization to vertical by using a half-wave plate. This 
makes the pump polarization extraordinary. Parametric light from the preamplifier stage is 
amplified by overlapping the beam from the preamplifier stage with the remaining 70 joJ of 
blue light reduced with a 2x telescope in a 2 mm type I BBO crystal. In the preamplifier 
stage, type H process is undergoing, so the polarizations of the signal (o) and idler (e) are 
different. Although both the signal and idler are transmitted amplifier stage at which type I 
process (e -> o + o) is undergoing, only the signal is amplified since the polarization of the 
idler generated in the preamplifier stage is orthogonal to that generated in the amplifier stage. 
Spot sizes are 1.2 mm and 1.4 mm for the pump and the output of the preamplifier stage, 
respectively. The pump intensity for the amplifier stage is 25 GW/cm2. The signal is 
separated from the idler by use of a dichroic beam splitter. The signal output energy is 
typically 2-3 |jJ/pulse, with a wavelength tuning range of475-820 run. Tuning can be done 
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easily by adjusting the timing and the crystal angle of the preamplifier stage, and minor 
timing adjustment is needed for the amplifier stage. 
2.4 PUMP-PROBE EXPERIMENT 
A mechanical chopper synchronized to one half the repetition rate of the laser is used to 
block every other pump pulse. The pump beams are focused onto the sample using a 150 
mm fl. lens, and the probe beam is focused using a 500 mm £1. lens. The pump energy is 
adjusted by using a half waveplate and a thin film polarizer combination. The probe and 
reference beams are vertically displaced, and sent into a monochromator (ISA HR-320) with 
a grating blazed at 1200 g/mm. The probe and reference beams are detected with Hamamatsu 
S1336-5BQ photodiodes, and amplified with Analog devices op467 precision high-speed OP 
amps. The outputs are measured and averaged with gated integrator and boxcar averager 
modules (Stanford Research Systems SR 250), subsequently to an analog processor module 
(Stanford Research Systems SR 235) where the probe signal is divided by the reference to 
provide a shot-to shot normalization. The natural log of the quotient is calculated in the 
module, and sent to a third boxcar averager, which is operated in toggle mode to do an active 
baseline subtraction. Then averaged outputs are converted to digital signal in the A/D board, 
and sent to a personal computer (Figure 2.14). Data sets are typically the average of twenty 
scans, with each point in the scan being an average of five hundred shots. Optical densities 
of the samples for the transient absorption experiments are 0.2-0.7 (concentration < 10^ M) 
at the excitation wavelength for 1-mm pathlength cells. Samples are stored in the 1mm 
pathlength spinning cells, and rotated during the experiment to prevent thermal lensing and 
sample degradation. 
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Figure 2.14 Schematic diagram of pump-probe experiment. X/2 WP: half wave plate, TFP: 
thin film polarizer, MC: monochromator, PD: photodiode, LBO I: type I lithium triborate 
crystal 
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2.5 THE FLUORESCENCE DECONVERSION SPECTROMETER 
Fluorescence upconversion is a powerful technique that is complementary to transient 
absorption. Transient absorption monitors all absorbing and emitting species (via stimulated 
emission), given an adequate signal-to-noise ratio. In transient absorption, it is hard to 
distinguish ground-state bleaching from stimulated emission in regions where the emission 
spectrum overlaps the absorption spectrum. Also, the spectrum from emitting species may 
often be obfuscated by the presence of absorbing species (singlets and triplets) present in 
higher concentration or with a larger extinction coefficient. Because the upconversion 
technique detects only emission from the excited state, the potential ambiguities in the 
transient absorption experiment referred to above can be eliminated. 
The fluorescence upconversion apparatus is described in detail elsewhere [43, 44,45], 
and is based on a Ti:sapphire oscillator, producing tunable (750-900 nm) 50-65-fs pulses 
(Figure 2.15). Sample is excited by frequency-doubled pulses. The residual fundamental 
wavelength after frequency doubled is used as the gate pulse to upconvert the fluorescence, 
which is collected and focused into a 0.4-mm BBO crystal with an ellipsoidal reflector. After 
separation from the gate beam, from the second and third harmonic beams, and from the 
fluorescence, the upconverted signal is focused into a monochromator coupled to a 
Hamamatsu R760 photomultiplier selected for zero dark counts. The instrument response 
function is obtained by collecting a cross correlation function of the second harmonic and the 
fundamental: the resulting third harmonic is plotted against delay time. Cross correlation 
functions typically have a fwhm of 140-144 fs. All curves were fit and deconvo luted from 
the instrument function using an iterative convolute-and-compare nonlinear least-squares 
algorithm. 
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Figure 2.15 Schematic diagram of the fluorescence upconversion spectrometer. Ti: sapphire 
oscillator is located within the box region with GVD precompensator. BS: beam splitter, 
L:lens, M: mirror, OC: output coupler, HR: high reflector, MC: monochromator, P: prism. F: 
filter 
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CHAPTER 3: CONFIRMATION OF EXCITED-STATE PROTON 
TRANSFER AND GROUND-STATE HETEROGENEITY IN 
HYPERICIN BY FLUORESCENCE UPCONVERSION 
A paper published in the Journal of the American Chemical Society1 
D. S. English2, K. Das2, K. D. Ashby2, J. Park2, J. W. Petrich *2, and E. W. Castner, Jr. *3 
ABSTRACT 
Fluorescence upconversion measurements of hypericin and its methylated analog, O-
hexamethoxy hypericin, which possesses no labile protons, confirm excited-state proton (or 
hydrogen atom) transfer as the primary photophysical event in hypericin. The presence of a 
rising component in the time-resolved fluorescence of hypericin and the absence of such a 
component for the hexamethoxy analog are consistent with our assignment of excited-state 
proton or atom transfer as the primary photophysical process in the light activated antiviral 
compound, hypericin. The results using the fluorescence upconversion technique, which 
detects only emission from the excited state, are in good agreement with our previous 
transient absorbance measurements. The results are also consistent with a heterogeneous 
ground-state of hypericin. 
'Reprinted with permission from The Journal of the American Chemical Society, 1997,119, 
11585. Copyright © 1997 American Chemical Society 
2Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111. 
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INTRODUCTION 
Interest in the polycyclic quinone, hypericin (see re£ 1 for reviews, Figure 3.1a) was 
spawned by the discovery that it possesses extremely high toxicity towards certain viruses, 
including HIV, and toward tumors [2-4] and that this toxicity absolutely requires light [5]. 
The interaction of light with hypericin and hypericin-like chromophores is clearly of 
fundamental biological importance. Previously we have used ultrafast time-resolved transient 
absorption spectroscopy as a tool to understand the excited state processes of hypericin (and 
its analog hypocrellin) [6-13]. We have concluded that the primary nonradiative process [38] 
in hypericin is excited-state intramolecular proton (or atom) transfer. 
In this work, we make use of a complementary technique, fluorescence upconversion, 
to measure the excited state dynamics. In fluorescence upconversion spectroscopy, an 
ultrashort laser pulse populates the excited state of the sample. The molecular emission is 
collected efficiently, and imaged into a nonlinear optical, or gating crystal. The spontaneous 
emission is gated, or "upconverted" by using a replica of the excitation pulse: the sum of the 
emission light frequency and the gating pulse is detected as a function of gate pulse delay 
time. The excited state dynamics, as manifested by the spontaneous emission transients, can 
be observed with <25 fs time resolution in this way. This technique provides the shortest 
possible time resolution for spontaneous emission dynamics, at least an order of magnitude 
better than available with direct detection techniques using streak cameras. 
Our argument for intramolecular excited-state proton transfer in hypericin is as 
follows. The hypericin analog lacking labile protons, mesonaphthobianthrone [14] (Figure 
3.Id), is significantly fluorescent and has optical spectra that resemble those of hypericin only 
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c) d) 
Figure 3.1 Structures of a) hypericin, b) one of the three possible hypericin double tautomers 
[7] (there are two possible monotautomers), c) O-hexamethoxy hypericin, and d) 
mesonaphthobianthrone. 
when its carbonyl groups are protonated [6,7] (Figure 3.2). Previously, we have argued that 
the fluorescent state of hypericin grows in on a time scale of several picoseconds, based on 
transient absorption measurements interpreted in terms of the rise time of stimulated emission 
of one species and the concomitant decay of transient absorption, of another species. 
Therefore, the combined observations of the requirement of protonated carbonyls for strong 
hypericin-like fluorescence and the rise time of fluorescence in hypericin was taken as 
evidence for intramolecular excited-state proton transfer in hypericin [7,8]. This conclusion 
was further strengthened by a comparison of the transient absorlbance of hypericin and its 
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methylated analog, O-hexamethoxy hypericin [9,10]. The assignment of proton transfer also 
was supported by the observation of a deuterium isotope effect of 1.4 in the excited-state 
transients of the hypericin analog, hypocrellin [13]. 
The interpretation of transient absorbance data, however, can be subject to 
complications because they measure ground-state bleaching, absorption of all excited states 
present (both singlet and triplet), and stimulated emission [9,10]. Because fluorescence 
upconversion monitors emission only from the fluorescent singlet state, it is not subject to 
these complications and hence provides complementary information not subject to the same 
ambiguities. The fluorescence upconversion measurements presented here clearly reveal a 
rising component of ~7 ps in the emission of hypericin and the absence of such a component in 
the emission of hexamethoxy hypericin, which cannot execute excited-state proton transfer. 
Of special relevance to the role of labile protons for light-induced antiviral activity is 
the observation that hypericin acidifies its surroundings upon light absorption [15-17], and 
that it retains its toxicity in the absence of oxygen [18]. The retention of toxicity in the 
absence of oxygen excludes unique assignment of antiviral activity to the trivial generation of 
singlet oxygen—even though hypericin does generate triplets in high yield (—70%) [19-21]. 
Thus, the role of photogenerated protons takes on additional significance, especially in the 
context of the growing body of literature implicating pH decreases with pharmacologically 
important functions, such as virucidal activity [22], antitumor activity [23,24], apoptosis (a 
form of cell death associated with DNA fragmentation and chromatin condensation) [25-27], 
and the subcellular distribution of hexokinase [28]. We have proposed a chemiluminescent 
means of activating the pharmacological activity of hypericin and its analogs [Id, 29]. 
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EXPERIMENTAL 
Hypericin [Carl Roth GmbH (for transient absorption measurements) or Molecular 
Probes (for upconversion measurements)] was used as received. Anhydrous DMSO from 
Aldrich was used (freshly opened) without further purification O-Hexamethoxy hypericin 
was prepared as described elsewhere [9], dissolved in DMSO, and kept under argon for both 
the upconversion and transient absorbance experiments. (Falk and Mayr have reported the 
synthesis of an 0-hexamethoxy hypericin [30].) Storage under argon was necessary to 
prevent the hexamethoxy sample from degrading, possibly from singlet oxygen formation 
Steady-state absorbance spectra were obtained on a Perkin Elmer Lambda 18 double-beam 
UV-vis spectrophotometer with 1-nm resolution Steady state fluorescence spectra were 
obtained on a Spex Fluoromax with a 4-nm bandpass and corrected for detector response. 
The apparatus for transient absorbance measurements is based on an amplified, 
homemade Tizsapphire laser system producing pulses of less than 200 fs fwhm at a variable 
repetition rate as high as 10 kHz. This system is described in detail elsewhere [9]. 
The fluorescence upconversion apparatus is described in detail elsewhere [31,32] and 
is based on a Tizsapphire oscillator (Spectra Physics, Tsunami) producing tunable (750-900 
nm) 50-65-fs pulses. Frequency-doubled pulses are used to excite the sample. The residual 
fundamental wavelength is used as the gate pulse to upconvert the fluorescence, which is 
collected and focused into a 0.4-mm BBO crystal with an ellipsoidal reflector. The 
upconverted signal is separated from the gate beam, from the second and third harmonic 
beams, and from the fluorescence; and it is focused into a monochromator coupled to a 
Hamamatsu R760 photomultiplier selected for zero dark counts. The instrument response 
Figure 3.2 Steady-state absorbance ( ) and emission ( )spectra of (a) 
hypericin in DMSO and (b) 0-hexamethoxyhypericin in DMSO. Also presented are 
emission and absorption spectra for mesonaphthobianthrone (mnb (c)) in DMSO ( 
), methanol ( ), and sulfuric acid ( ). In panels a and b, the arrows denote 
the detection wavelengths selected for the transient absorbance and upconversion 
experiments. Mesonaphthobianthrone (mnb) was prepared (Id) according to the 
procedure of Koch et al. (39). A synthesis of this compound has also been reported by 
Falk and Vais burg (14). The absorption spectra of mnb in DMSO and methanol are of 
higher quality than those presented earlier (Id,7) where the very weak features were 
hidden by scattering and other artifacts. Note, that the absorption spectra in these 
solvents are multiplied by a factor of 10 in order to compare them with those in sulfuric 
acid. In all cases, the emission spectra are normalized to have the same intensity as the 
corresponding absorption spectra. In order to compare the absorption and emission of 
hypericin with that of mnb, we cite their extinction coefficients and the fluorescence 
quantum yields of mnb relative to that of hypericin in DMSO. Hypericin/ethanol: e(590 
nm) = 40 000 cm"1 M"1 (40); 4>F = 1.00 (the absolute value is conventionally taken as 
0.3)(19). Mhb/DMSO: e(428 nm) = 850 cm"1 M"1; <f>p = 0.056. Mnb/methano 1: e(468 
nm) = 510 cm"1 M"1 ; <|>F = 0.11. Mhb/HzSO*: e(510 nm) = 3.0 x 104 cm"1 MT1; 4>F = 1.5. 
The extinction coefficients we have obtained for mnb in DMSO and methanol are subject 
to considerable uncertainty. Mnb is very insoluble in these solvents; light scattering from 
undissolved material, as well as the presence of impurities, contributes to the poor quality 
of the absorption spectra. Falk and Vaisburg (14) report e(423 nm) = 7000 cm"1 M"1 in 
DMSO. The spectra they obtain, especially in methanol, bear qualitative similarity to 
those presented here. The relative fluorescence quantum yields of mnb in DMSO and 
methanol must be considered to be upper limits, since even a small amount of highly 
fluorescent (i.e., long-lived) impurity can contribute to the measured value (10). The 
value obtained in H2SO4 is more certain than those obtained in DMSO or methanol, since 
in H2SO4 mnb is much more fluorescent and has a relatively long-lived fluorescence 
lifetime of 15 ns (7). 
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function is obtained by collecting a cross correlation function of the second harmonic and the 
fundamental: the resulting third harmonic is plotted against delay time. Cross correlation 
functions typically have a fwhm of 140-144 fs. All curves were fit and deconvoluted from the 
instrument function using an iterative convolute-and-compare nonlinear least-squares 
algorithm. 
RESULTS AND DISCUSSION 
Steady-state absorption and emission spectra for hypericin and 0-hexamethoxy 
hypericin are given in Figure 3.2. Also included in Figure 3.2 are absorption and emission 
spectra for the simplest hypericin analog that we have investigated, mesonaphthobianthrone. 
As we note in the Introduction, this compound has played a pivotal role in our early 
investigation of the hypericin photophysics and in our identification of intramolecular proton 
(or atom) transfer as the primary photoprocess. The spectra presented here are of higher 
quality than those we have previously reported [7, Id]. Figure 3.3 presents a comparison of the 
fluorescence upconversion and transient absorption traces for hypericin and hexamethoxy 
hypericin in DMSO. The fluorescence upconversion signal for hypericin clearly shows a rising 
component (~7 ps), which is not present in hexamethoxy hypericin. (Preliminary data indicate 
an ~2.5-ps rising component in ethanol). This result is consistent with results obtained using a 
pump wavelength of 588 nm, in which the rise time is fit to an ~11-ps component. 
The fluorescence upconversion signal of hypericin reveals significantly different 
kinetics in the first 40 picoseconds of the fluorescence decay at the two emission wavelengths 
investigated, 600 and 650 nm (compare Figure 3.3 and Figure 3.4). At 650 nm the ~7 ps 
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rising component is completely absent. As we discuss in the Conclusions section, these results 
support our previous suggestions that the ground state of hypericin is heterogeneous. 
Figure 3.5 presents data collected on a shorter time scale. For both hypericin and 
hexamethoxy hypericin at both emission wavelengths, there is evidence of an ~100-fs rise time 
in the upconversion signal. These ultrafast 100-fs risetimes are not instrumental artifacts. The 
same upconversion spectrometer has been used to observe fluorescence decays for various 
photoinduced electron transfer systems with lifetimes of < 50 fs [32] as well as a series of 
subpicosecond to several-picosecond decays which have a definite risetime [31a]. In the case 
of risetimes observed for fluorescent coumarin excited singlet states being reductively 
quenched by aromatic amine solvents, there is good reason to assign these -100-fs risetimes 
to inertial solvation dynamics, as the polar solvents librate about the very polar coumarin 
excited state [31b]. Solvation dynamics cannot, however, be invoked to explain the risetimes 
for the hypericins, as the emission displays only a small amount of solvatochromism, indicating 
a negligible difference between ground- and excited-state dipole moments for the hypericins. 
A likely assignment for the observed risetimes in the hypericins is internal conversion from a 
higher-lying singlet state, pumped by the ~415-nm laser pulses, to the lowest singlet excited 
state near 600 and 540 nm for hypericin and 0-hexamethoxy hypericin, respectively. 
Chudoba et al. have also assigned such 100-fs transients to internal conversion for a different 
excited-state proton-transfer molecule, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole [35]. 
Both in the Introduction and the Conclusion of this article, we note the potential ambiguities 
to which transient absorption measurements are subject. In this context, Figure 3.6 presents 
fits to previous transient absorption data in which the component previously described as a 
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Figure 3.3 Comparison of fluorescence upconversion and transient abso»rbance traces for 
hypericin in DMSO at Xem ~ ^-probe = 600 nm and for O-hexamethoxy hypericin in DMSO at 
Xem = Xprobe = 540 nm. These wavelengths correspond to the maxima in the steady state 
emission spectra of the respective compounds. In the absorption transients of O-hexamethoxy 
hypericin there is evidence for a rising component which is not present in the upconversion 
data. We have assigned this as a rise in the bleach that is attributed to at decay of excited state 
absorbance with a time constant of 2.6 ps. The data are fit to the following functions: 
a) F(t) = -0.19exp(-t/7.3 ps) + 1.0 exp(-t/co) 
b) AA(t) = 0.30 exp(-t/11.6ps) - 1.00exp(-t/oo) 
c) F(t) = 1.00exp(-t/oo) 
d) AA(t)=0.11 exp(-t/2.6 ps) — 1.20 exp(-t/480 ps) + 0.89 exp (-t/oo) 
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Figure 3.4 Fluorescence upconversion traces of hypericin at 650 nm and O-hexamethoxy 
hypericin at 580 nm. These wavelengths correspond to the second maxima (Figure 3.2) of the 
respective fluorescence spectra. The data are fit to the following functions: 
a) F(t) = 1.00 exp(-t/oo) 
b) F(t) = 1.00 exp(-t/503 ps) 
rise in stimulated emission is now attributed to a decay of one species whose excited-state 
absorption spectrum overlaps the emission spectrum of at least one other species. 
Fluorescence anisotropy decays were constructed from upconversion signals polarized 
parallel and perpendicular to the excitation beam. These are displayed in Figure 3.7 for 
hypericin and hexamethoxy hypericin. Of significance is that excitation at 410 nm gives rises 
to a negative anisotropy, Le., a negative prefactor, r(0). Elsewhere [33] we have presented a 
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Figure 3.5 Observation of an ~ 100-fs rise time in the fluorescence upconversion signal. The 
dashed lines are single exponential fits corresponding to an instantaneous risetime in the 
fluorescence signal Fitting the rise of the fluorescence signal to a rise time yields (solid lines): 
(a) F(t) =-0.91exp(-t/64 fs) + 1.00 exp(-t/oo) 
(b) F(t) =-0.83exp(-t/ 1146) + 1.00 exp(-t/oo) 
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Figure 3.6 Reconsideration of previously obtained transient absorption signals for hypericin in 
the light of upconversion data presented here. Top: Xex = 588 nm, XpTObe = 645 nm, ethylene 
glycol (7,8); AA(t) = -0.56 exp(-t/2.0 ps) + 0.43 exp(-t/6.4 ps) - 0.19. Middle: A.ex = 588 nm, 
Xprobe = 658 nm, DMSO (7,8); AA(t) = -0.19 exp(-t/2.0 ps) + 0.27 exp(-t/6.4 ps) - 0.30. 
Bottom: A*x = 415 nm, Xpmbc = 650 nm, DMSO (9); AA(t) = 0.21 exp(-t/8.0 ps) - 0.29. The 
spike at "zero time" is not considered in this fit because it is attributed to a cross-phase 
modulation artifact resulting from the ~150 fs pulses used in the experiment (9,10,41). It is 
unlikely that this is the case for the top trace, however, since the pulses used for this 
experiment were no shorter that 1 ps. In each case, the last term in the fit corresponds to a 
component that does not decay on the time scale of the experiment and that is attributed to 
the long-lived fluorescent species. 
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Figure 3.7 Polarized fluorescence traces and anisotropy curves. 
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detailed investigation of the dependence of the steady-state fluorescence-excitation anisotropy 
and have observed similar behavior: depending on the excitation wavelength, the prefàctor can 
be positive or negative. This results from the transition dipoles connecting the ground 
electronic state to the first two excited electronic states being at large angles to each other. If 
hypericin (which actually has a very twisted aromatic skeleton [13,34]) had C2v symmetry, 
these transition dipoles would be orthogonal. Also of interest is that the time constant for the 
anisotropy decay for hexamethoxy hypericin is roughly three times greater than that for 
hypericin and does not decay to zero on the same time scale. 
CONCLUSIONS 
The fluorescence upconversion technique with 100-fs resolution was applied to 
hypericin and its synthetic analog, O-hexamethoxy hypericin. The results of these studies 
were compared with previous results obtained by means of transient absorption spectroscopy. 
Fluorescence upconversion is a powerful technique that is complementary to transient 
absorption. Transient absorption monitors all absorbing and emitting species (via stimulated 
emission), given an adequate signal-to-noise ratio. It is difficult, if not impossible, to 
distinguish ground-state bleaching from stimulated emission in regions where the emission 
spectrum overlaps the absorption spectrum. Also, emitting species may often be obscured by 
the presence of absorbing species (singlets and triplets) present in higher concentration or with 
a larger extinction coefficient. We have discussed and addressed these complications in 
previous work [7,9,10]. Because the upconversion technique detects only emission from the 
excited state, the potential ambiguities in the transient absorption experiment referred to 
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above are obviated. The fluorescence upconversion results presented here are in complete 
agreement with the major results and conclusions we have already presented: namely, that 
excited-state intramolecular proton (or atom) transfer is a primary photophysical event for 
hypericin and its analogs with labile protons. The upconversion results also validate the 
transient absorption technique as a means of monitoring proton or atom transfer rates in 
hypericin, assuming that the transient absorption spectrum is well understood. 
In addition, the results presented here support our previous suggestions that the 
ground state of hypericin is heterogeneous [7,9,10], existing either as various tautomers or 
conformational isomers, and implies that the same argument can be made for hypocrellin and 
other hypericin analogs [11-13,33]. We originally suggested that the ground state of hypericin 
is heterogeneous in order to rationalize the mirror-image symmetry between its steady-state 
absorption and emission spectra [7,8]. Such symmetry is atypical of molecules whose excited 
states undergo nuclear rearrangements, such as proton or atom transfer. The archetypal 
excited-state proton-transfer system, 3-hydroxyflavone, provides a good example of the 
absence of such symmetry [36]. The transient absorption data obtained using different 
excitation wavelengths (415 and 588 ran) presented in Figure 3.6 yield different excited-state 
kinetics and are also suggestive of such heterogeneity. The upconversion results provide the 
most direct evidence to date for ground-state heterogeneity in hypericin at ambient 
temperatures [37]. Not only are the fluorescence profiles for hypericin different at the 
emission wavelengths of600 and 650 nm, but even at 600 nm there are, in addition to the 
-100-fs component, two components to the fluorescence risetime with 7-ps and 
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instantaneous" time constants. These may be attributed to untauttomerized and tautomerized 
(or at least partially tautomerized) species. 
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CHAPTER 4. IS THE EXCITED-STATE H-ATOM TRANSFER IN 
HYPERICIN CONCERTED? 
A paper accepted in Photochemistry and Photobiology 
J. Park, A Datta, P. K. Chowdhury, and J. W. Petrich* 
ABSTRACT 
The excited-state intramolecular H-atom transfer of hypericin (Hyp) was investigated as a 
function of pH in monodispersed reverse micelles formed by sodium bis(2-
ethylhexyl)sulfosuccinate/heptane/water and in complexes with Tb3+ under conditions in 
which one of the two carbonyl groups of Hyp is incapable of accepting a hydrogen atom. 
The results of pump-probe transient absorption experiments provide no evidence for a 
concerted H-atom transfer mechanism. 
INTRODUCTION 
Hypericin (Hyp) (Fig. 4.1) is one of many naturally and commonly occurring 
perylene quinone pigments that have stimulated great interest because of their broad 
spectrum of light-induced biological activities (1-5), among which are light-induced virucidal 
activity against several types of viruses, including the human immunodeficiency virus (HTV) 
(6-8), as well as antiproliferative and cytotoxic effects on tumor cells (9-11). Owing to this 
important biological activity, over the past few years we have been studying the photophysics 
of Hyp and its analogs (12-24). By means ofH/D substitution, investigation of O-methylated 
Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111. 
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Figure 4.1 Structures of hypericin: (a) "normal" form (b) monotautomer form and (c) double 
tautomer form 
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analogs, and complementary studies using both transient absorption and fluorescence 
upconversion spectroscopies, we have argued that the major primary photophysical process 
in organic solvents is exciteri-state hydrogen atom transfer. 
Given the structure of hypericin, with two sets of two hydroxy! groups peri to a 
carbonyl, one is naturally imelined to inquire how many hydrogen atoms are transferred in the 
excited state and, if more than one is transferred, whether the process is stepwise or 
concerted. (It is useful to note the difference between a concerted and a synchronous 
reaction. A concerted reaction takes place in a single kinetic step, with no reaction 
intermediate, where some orf the changes in bonding take place to different extents in 
different parts of the reactio-n. A synchronous reaction is one where all the bond-making and 
bond-breaking processes take place at the same time and proceed at the same extent during 
the reaction (25, 26). It is a common error to assume that concertedness implies synchrony.) 
We have previously observed that when Hyp is bound to human serum albumin 
(HS A), it no longer undergoes an excited-state hydrogen atom transfer. Assuming that the 
binding occurs through the interaction of one of the two carbonyl groups of hypericin and the 
Ni-H of the single tryptophan residue (W214), which would necessarily impede H-atom 
transfer on this half of the Hyp molecule, we suggested that the absence of H-atom transfer in 
the complex was indicative of concerted, double H-atom transfer in the excited state of Hyp 
(20). 
Here, we investigate: the effects that are induced by impeding the excited-state H-
atom transfer by protonating one of the carbonyl groups of Hyp, or by complexing it with a 
metal ion, such as Tb3+. Jar-don and coworkers (27-32) have produced a large body of careful 
work on the steady state spectra and the triplet photophysics of Hyp in various conditions. 
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They were the first to study Hyp as a function of pH in Brij-35 micelles (27) and the triplet-
state photophysics of Hyp/metal complexes (33). 
MATERIALS AND METHODS 
Hypericin was purchased from Molecular Probes and was used as received. Sodium 
bis(2-ethylhexyl)sulfo succinate (AOT) purchased from Sigma Chemucal Co. (St. Louis, 
MO), was purified by dissolving in methanol and stirring it overnight in the presence of 
activated charcoal Subsequent filtration and removal of methanol by distillation under 
vacuum yielded AOT suitable for use. Spectrophotometry grade heptane (Hep) purchased 
from Aldrich was refluxed over calcium hydride and collected by distillation before use. 
TbCls 6H2O was obtained from Aldrich. 
Preparation of Sample: Reverse micelles formed by dissolving AOT in Hep 
provide an ideal system because their size and properties may be very well controlled. 
AOT/H2O reverse micelles are well characterized regarding their size, shape and the number 
of AOT molecules per aggregate, i.e. the aggregation number (34). Addition of water to 
AOT/alkane solutions produces systems that resemble small water pools in bioaggregates 
(34). The polarity of the AOT/alkane solutions increases with the fraction of water inside the 
pool, with the stability of the micelles being determined by the concentration ratio: wo = 
[H20]/[A0T]. The nature of the water present in reverse micelles, as well as the interactions 
between reverse micelles and small molecules, has been discussed in a recent review by 
Siber et al. (35). Eastoe et al. have shown that the microemulsion droplets are spherical for 
Na+ and Ca2+ counterions, but become rod-shaped for Co2+, Ni2+, Cu2+ and Zn2+ counterions 
(36). At the very low probe to surfactant ratio used in our studies, it can be safely assumed 
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that the structure of the reverse micelles are not affected to any serious extent by the presence 
of Hyp or its ions. The solution of AOT in Hep was prepared in such a way that the 
concentration was 0.9 M. Hypericin is insoluble in Hep and dissolves very slowly in the 
AOT/Hep reverse micellar system. On addition of water, however, hypericin dissolves much 
more readily. The color of the reverse micellar system with hypericin was red at low pH and 
at intermediate pH values, while at a pH of 13, the solution had a dark green color. The basic 
solution, however, slowly reverts to the red color characteristic of Hyp in AOT/Hep, 
indicating a gradual shifting of the equilibrium towards the "normal" form (the 7,14 diketo 
tautomer, displayed in Figure 4.1a). The concentration of Hyp was kept at —10^ M (such a 
concentration of Hyp was necessary to obtain a sufficiently large signal in pump-probe 
transient absorption experiments). The pH was maintained by HC1 of appropriate molarity 
and its subsequent neutralization by 0.1 M NaOH solution. The pH was recorded by a 
manual Fisher-Accumet (955) Mini pH meter. All measurements were carried out at 298K. 
To determine the stoichiometry of the Hyp/Tb34" complexes, a Job plot was 
constructed using 5 x 10"5 M solutions of Hyp and TbClg 6H2O, in varying proportions, 
keeping the total volume constant. The solutions were allowed to stabilize overnight before 
absorbance measurements of the complex were performed at 680 nm, a wavelength where 
free Hyp does not absorb. Absorption and emission spectra of the complex are given in 
Figure 3. In order to determine the binding constant for the complex, a Benesi Hildebrand 
plot was constructed, assuming a 1:1 stoichiometry obtained from the Job plot. The 
concentration of hypericin was 1 x 10"5 M. The concentration ofTbCl] was varied from 2 x 
10~* M to 2 x 10"3 M. A large excess of the terbium salt was used in order to satisfy the 
condition that the equilibrium concentration of the metal ion was practically the same as the 
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initial concentration. Absorption measurements were performed at 640 nm. To prepare the 
Hyp /terbium complexes for the pump probe experiment, a solution of 5 x 10^ M Hyp in 
ethanol was prepared and solid TbCls 6H%0 was added to make the solution 0.2 M in the salt. 
The Hyp:TbCl3 ratio was maintained at 1:400 in order to make sure that practically all the 
hypericin molecules were in the chelated form and there was no signal from free Hyp. 
Spectroscopic Measurements: Steady-state absorption spectra were recorded on a 
Perkin-Elmer Lambda-18 double-beam UV-visible spectrophotometer with 1-nm resolution. 
Steady-state fluorescence spectra (both excitation and emission), were obtained on a SPEX 
Fluoromax with a 4-nm bandpass (a smaller bandpass, up to 2-nm, was used in some cases to 
avoid saturating the detector to preserve linearity in response), and corrected for detector 
response. For both fluorescence and absorption measurements, a 1-cm path-length quartz 
cuvette was used. 
The apparatus for pump-probe transient absorption measurements and the analysis of 
the kinetic data are described in detail elsewhere (23, 37). 
RESULTS AND DISCUSSION 
Effect of Protonating the Carbonyl Group 
The effect of pH on the absorption and emission spectra of Hyp in AOT reverse 
micelles is given in Figure 4.2. The length of the hydrocarbon chain of AOT is 9 Â. 
Because the hydrocarbon chain is shorter than both dimensions of Hyp (major axis, 10.5 Â; 
minor axis, 9.6 Â), it is most likely that two peri hydroxyl and the intervening carbonyl 
groups of Hyp protrude into the polar core (38). It is very improbable that any significant 
amount of water permeates the extremely apolar and hydrophobic chains of the AOT (39, 40) 
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Figure 4.2. Absorption ( ) and emission ( ) spectra of hypericin (5 x 10^ M) in 
dimethylsulfoxide and in AOT/water/ «-heptane reverse micelle (WQ = 2) at different 
concentrations of HC1 (pH = 6, 1.2 and 0.5 M HC1). We were unable to probe more acidic 
environments due to the instability of the reverse micelles under such extreme conditions. 
The excitation wavelength for the emission spectra is 550 nm. For [AOT] = 0.9 M and [Hyp] 
= 5 x 10"* M there are about 100 micelles for every Hyp molecule. It should be noted that we 
use the term "pH" to refer to the pH of the water prior to addition to the reverse micellar 
system. The effective pH within the reverse micelles is expected to be correlated, but not 
identical to these pH values. As pointed out by El Seoud (42), the apparent pK* in the reverse 
micellar system differs from that in bulk water due to a combination of medium and 
electrostatic effects. 
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, and hence, this environment is very unlikely to accommodate H*" or OH-, or any charged 
species. We thus conclude that in AOT reverse micelles, the only groups of Hyp susceptible 
to titration are those protruding into the polar core. 
From the results summarized in Table 4.1, a clear rise in the stimulated emission, 
with a time constant of 10 ps, is observed in the transient absorption kinetics of hypericin in 
AOT reverse micelles, both in 0.5 M HC1, where the exposed carbonyl groups are expected 
to be completely protonated, and at pH 6, where they remain fully unprotonated. Thus, 
protonation of the carbonyl group in the reverse micelles does not impede the H-atom 
transfer of the part of the molecule buried in the hydrophobic portion of the micelle. The 
complementary experiment of measuring the kinetics when the peri hydroxyls are 
deprotonated could not be performed because Hyp /AOT is unstable at pH > 12 (38). 
Table 4.1. Global fitting parameters for hypericin in AOT/water/n-heptane reverse micelles 
(w0=2)* 
0.5 M HC1 ai Tl (ps) a2 
590 nm 0.01 10.5 -0.16 
596 nm 0.05 10.5 -0.17 
600 nm 0.03 10.5 -0.16 
Neutral pH 
590 nm 0.04 10.3 -0.16 
596 nm 0.04 10.3 -0.16 
600 nm 0.02 10.3 -0.16 
'Transient absorption data are fit to the function: AA(t)= at exp(-t/xi ) + a% exp(-t/T2 ). The 
preexponential factors are all normalized and should not be interpreted in terms of absolute 
optical density changes owing to changes in pump intensities and gain settings on data 
acquisition hardware. In all cases, = oo since the time scale on which the experiment is 
performed does not permit its determination. 
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Effect of Chelating the Carbonyl Group to Tb3* 
The steady-state spectra of the Hyp /Tb3+ complex are given in Figure 4.3. Its 
stoichiometry is 1:1 and its binding constant is 1.6 x 104. The small peaks at 590 and 620 nm 
likely arise from the very few Hyp molecules that are not chelated. We have measured the 
quantum yield of the chelate to be 5 x 10"5, approximately 600 times less than that of free 
Hyp; thus, even a very small amount of the free molecule is sufficient to give rise to a 
perceptible fluorescence intensity. Under our experimental conditions, only one carbonyl is 
chelated. Transients of 10 ps are observed in the traces obtained at probe wavelengths 
ranging from 520-650 nm (Table 4.2 and Figure 4.4); but it is unlikely that they result from 
excited-state H-atom transfer. This time constant reflects, rather, the lifetime of the first 
excited singlet state of the complex, which decays rapidly owing to intersystem crossing. 
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Figure 4.3. Absorption (a) and emission (b) spectra of Hyp/Tb3+ complex in ethanol. The 
concentrations of hypericin and TbCl] 6H%0 are 1.1 x 10"5 M and 4 x 10"3 M, respectively. 
The spectra are normalised to the reddest absorption maximum. The excitation wavelength 
for the emission spectrum is 490 nm. 
87 
Table 4.2. Global fitting parameters for the hypericin/Tb3+ complex in ethanof 
ai Tl (ps) a2 
520 nm -0.32 10.2 0.97 
530 nm 0.00 10.2 0.97 
550 nm 0.00 10.2 0.90 
570 nm 0.29 10.2 0.59 
580 nm 1.27 10.2 -0.18 
600 nm -0.69 10.2 -0.24 
630 nm -0.76 10.2 -0.36 
650 nm -0.77 10.2 -0.36 
'Transient absorption data are fit to the function: AA(t)= ai exp(-t/xi ) + a2 exp(-t/r2 ). The 
preexponential factors are all normalized and should not be interpreted in terms of absolute 
optical density changes owing to changes in pump intensities and gain settings on data 
acquisition hardware. In all cases, T2 = oo since the time scale on which the experiment is 
performed does not permit its determination. 
The rise of the triplet species is evident at 520 nm, the maximum of the triplet-triplet 
absorption spectrum of free Hyp and the complex (33). The negative-going signals from 
630-650 nm are attributed to the ground-state bleaching of the complex. We conclude that 
any component of stimulated emission with a 10 ps rise time is too weak to be detected. Its 
presence is obfuscated by the concomitant 10 ps decay of excited-state absorbance, most 
clearly evident at 580 nm. 
CONCLUSIONS 
The results presented above indicate that excited-state H-atom transfer occurs in Hyp 
even when one of the carbonyls is prohibited from accepting a hydrogen. The presence of 
such a transfer is apparent under very acidic conditions in AOT reverse micelles and cannot 
be excluded upon chelation of Tb3+. There is, thus, no evidence for a concerted hydrogen-
atom transfer mechanism in hypericin. We are, however, unable to conclude from the 
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Figure 4.4. Transient absorbance traces of the Hyp/Tb3+ complex in ethanol at probe 
wavelengths of (a) 520 nm, (b) 530 nm, (c) 550 nm, (d) 570 nm, (e) 580 nm, (f) 600 nm, (g) 
630 nm and (h) 650 nm. The pump wavelength was 407 nm. The concentrations of Hyp and 
TbCls were 5 x 10"* M and 0.2 M, respectively. The global fits to these decays are presented 
in Table 5.2. 
present study if only one hydrogen atom is transferred or if two are transferred in a stepwise 
fashion. It remains, then, to question why H-atom transfer is completely impeded when 
hypericin binds to HSA (20). The answer may lie in the requirement for skeletal motion to 
be coupled to the H-atom transfer (41,24). Fluorescence anisotropy measurements of the 
HSA/hypericin complex indicate that the Hyp is rigidly bound and that there is no rapid 
restricted motion of Hyp relative to the protein. Although this response is plausible, it is not 
easy to reconcile it with the observation that Hyp undergoes H-atom transfer in a glass at low 
temperatures (21), where the amplitude of skeletal motion would seem to be less than that in 
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the HS A matrix. One would need to conclude from the two observations that the protein 
provides a more constrained environment than the glass. These sorts of problems and 
questions continue to illustrate the need for further elucidation of the reaction coordinate for 
the H-atom transfer in Hyp and its analogs (24). 
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CHPTER5: IDENTIFICATION OF A VIBRATIONAL FREQUENCY 
CORRESPONDING TO H-ATOM TRANSLOCATION IN HYPERICIN 
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ABSTRACT 
By means of time-resolved infrared spectroscopy, ab initio quantum mechanical 
calculations, and synthetic organic chemistry, a region in the infrared spectrum, between 
1400 and 1500 cm"1, of triplet hypericin has been found corresponding to translocation of the 
hydrogen atom between the enol and the keto oxygens, OeeeHeeeO. This result is discussed 
in the context of the photophysics of hypericin and of eventual measurements to observe 
directly the excited-state H-atom transfer. 
INTRODUCTION 
Hypericin (Figure 5.1) is one of many naturally and commonly occurring perylene 
quinone pigments that have stimulated great interest because of their broad spectrum of light-
induced biological activities (1-4), among which are light-induced virucidal activity against 
several types of viruses, including the human immunodeficiency virus (HIV) (5-7), as well as 
antiproliferative and cytotoxic effects on tumor cells (8-10). Owing to this important 
1 Department of Chemistry, Iowa State University, Ames, Iowa 50011-3 111. 
2 Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218-2685 
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normal double tautomer 
CH, 
..«CH, 
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Figure 5.1. Hypericin in several tautomeric forms: upper left, the 7,14-dioxo tautomer 
("normal" form); upper right, the 1,6-dioxo tautomer (a double tautomer); bottom left, the 
6,14-dioxo monotauotomer; bottom right, the 7,13-dioxo monotautomer). The portions of 
the aromatic skeletons highlighted in bold indicate regions that are conserved upon 
tautomerization (24,50) and that thus contribute to the observed mirror image symmetry 
between the absorption and fluorescence spectra. 
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biological activity, over the past few years we have been studying the photophysics of 
hypericin and its analogs, such as hypocrellin (Figure 5.2 ) (11-22). By means of HZD 
substitution, investigation of ^-methylated analogs, and complementary studies using both 
transient absorption and fluorescence upconversion spectroscopies, we have argued that the 
major primary photophysical process is excited-state hydrogen atom transfer. 
There are two objections, nevertheless, that are still occasionally raised to this assignment. 
These are the absence of a deuterium isotope effect for the 10-ps component of hypericin 
and hypocrellin and the mirror image symmetry between the absorption and emission spectra 
in hypericin and hypocrellin. 
We have extensively discussed the lack of a deuterium isotope effect 
(23,12,15,17,24). Its absence is easily attributed to the reaction coordinate not being 
identified with the proton coordinate. There is precedent for this in other systems (25-27). 
Requiring the absence of mirror image symmetry between the absorption and emission 
spectra assumes that the potential energy surface of the emitting species is significantly 
different from that of the absorbing species. Such a displacement in the coordinate of the 
emitting species is clearly evident in the most commonly studied proton transfer systems: 
methyl salicylate (26,28); 7-azaindole dimer (29,30); 2-phenyl-benzotriazole (31); and 3-
hydroxyflavone (32-36). 
If, however, we consider systems in which the normal and tautomer species are 
symmetric, or nearly so, this disparity no longer exists or is significantly minimized. 5-
Hydroxytropolone (37-39) presents an excellent example of such a case. Other examples are 
the double H-atom transfer in naphthazarin (40) and in the 4,9-dihydroxyperylene-3,10-
quinone subunit of hypocrellin, producing entirely symmetric structures. 
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Figure 5.2. Steady-state absorption (—) and emission (—) spectra of. (A) hexacetoxy analog 
in acetonitrile excited at 270 nm; (B) hexamethoxy hypericin in dimethyl sulfoxide excited 
at 480 nm; and (C) hypericin in acetonitrile excited at 550 nm. 
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We argue that hypericin and hypocrellin A have very similarly symmetric normal and 
tautomeric forms as indicated by the highlighted bond systems in Figure 5.1. That is, 
regardless of the tautomeric form in which the molecule finds itselfj there is always 
conserved an aromatic core to which is attached a hydroxyl group peri to a carbonyl group. 
Even in the case of the monotautomerized species, it is possible to draw resonance forms that 
upon superposition restore the aromatic character of the substructure involved in the H-atom 
transfer reaction. Consequently, we conclude that the mirror image symmetry observed in 
hypericin and hypocrellin is not at all surprising. 
We recognize, however, that no matter how satisfactory one finds the above 
reasoning, a direct demonstration of an excited-state H-atom transfer requires measurements 
of the carbonyl or hydroxyl stretching frequency as a function of time subsequent to laser 
excitation. Such measurements require a tunable infrared probe source coupled to a visible 
or ultraviolet pump pulse. A first step in this process is the identification of vibrational 
modes that are indicative of translation of the hydrogen atom between the enol and the keto 
oxygens. 
MATERIALS AND METHODS 
Sample Preparation. Hypericin and hypocrellin A were obtained from Molecular 
Probes and used without further purification. Hexamethoxy hypericin was prepared as 
previously described (41). Hexaacetoxy-2,2'-dimethylmesonapthodianthren (42) was 
prepared as follows. A mixture of hypericin (0.07 g) and anhydrous sodium acetate (0.07 g) 
in acetic anhydride (7 mL) was boiled for 5-10 minutes. Over 30 minutes, small portions of 
zinc powder (1.9 g) were added to the boiling solution until the color changed to yellow. The 
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reaction was cooled to room temperature and filtered through a pad of Ce lite. The filtrate 
was concentrated in vacuo to obtain a yellow residue which was purified by preparative thin 
layer chromatography using hexanes: ethyl acetate. The yield of product was 25%. NMR 
(CDC13): 2.02 (s, 3 H), 2.20 (s, 3 H), 2.35 (s, 3 H), 2.37 (s, 3 H), 3.97 (s, 2 H), 4.12 (s, 2 H), 
6.77 (s, 1 H), 7.13 (s, 1 H), 7.19 (s, 1 H), 7.24 (s, 1 H). MS m/z 728,670, 628, 586, 560, 
458. 
Time-Resolved Infrared Spectroscopy. The solutions were prepared in the dark in 
acetonitrile-^#, obtained from Cambridge Isotope laboratories and used as received. Sample 
concentrations were: hypericin, 5 x 10'5 M; hexa O-methyl hypericin, 2 x 10^ M; 
hexacetoxy analog, 9.2 x 10"4 M. The solutions were purged with a constant flow of argon 
during the experiments. The TRIR measurements are described in detail elsewhere (43). The 
broad-band output of a MoSi2 IR source (JASCO) was overlapped, on the sample contained 
in a flowing cell, with the excitation pulses from a Quantronix Q-switched Nd:YAG laser 
(355 nm, 90 ns, 1.5 mJ) operating at 200 Hz. Changes in IR intensity were monitored by a 
MCT photovoltaic IR detector (Kolmar Technologies, KMPV 11 - 1 - Jl), amplified and 
digitized with a Tektronix TDS520A oscilloscope. The experiment was conducted in the 
dispersive mode with a JASCO TRIR - 1000 spectrometer. TRIR difference spectra were 
collected at 16 cm*1 resolution. 
Time-resolved Visible Absorption Spectroscopy. The apparatus used for ultrafàst 
kinetic measurements is described in detail elsewhere (22,41). 
Ab initio Quantum Mechanical Calculations. Details are given elsewhere (44). 
Initial structures for all minima were obtained with the senaiempirical AMI (45) molecular 
orbital method. Using these structures as starting points, the geometries were then optimized 
toi 
at the restricted Hartree-Fock (RHF) level of theory for closed shell singlet ground states and 
restricted open shell Hartree-Fock (ROHF) for the excited triplet states, using the 3-21G 
basis set (46). At each RHF/3-21G stationary point, the Hessian, (matrix of energy second 
derivatives) was calculated using finite double differencing of the analytic gradients. The 
Hessian is used to determine the nature of each stationary point (positive definite for a local 
minimnmJ one negative eigenvalue for a saddle point) and to provide an estimate of the 
vibrational frequencies and the vibrational zero-point energies. All calculations discussed 
here were performed with the electronic structure code GAMESS (47). 
RESULTS AND DISCUSSION 
Figure 5.2 presents a comparison of the steady-state absorption and emission spectra 
of the hexaacetoxy analog, hexamethoxy hypericin, and hypericin. These data indicate that 
both the hydroxy Is peri to the carbonyl groups and the carbonyl groups themselves play 
significant roles in determining the form of the spectra of hypericin. The presence of the 
carbonyl groups at the 7 and 14 positions is the more important of the two factors. 
Figures 5.3 and 5.4 compare the transient absorption kinetics of the hexaacetoxy analog and 
of hypericin, respectively: the analog clearly lacks the ~10-ps rising component that is the 
signature of excited H-atom transfer in hypericin. This rising component is also absent in the 
kinetics of hexamethoxy hypericin (22,41). 
Figure 5.5 and Table 5.1 present the time-resolved infrared data for hypericin, 
hexamethoxy hypericin, and the hexaacetoxy analog lacking the 7,14 carbonyls. These 
spectra were obtained on the microsecond time scale, and hence they reflect the photophysics 
of triplet species and any possible photoproducts. Because the transient data are difference 
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Figure 5.3. Transient absorption traces (AA vs. time) of the hexacetoxy analog in 
acetonitrile, Xpump = 403 nm. A global fit to the kinetics at the six probe wavelengths 
presented yields a time constant of 43 ps. 
spectra, their features are considerably more pronounced than those of the ground-state 
spectra. 
The hexaacetoxy analog provides the simplest kinetics of the three analogs: only one 
transient is observed (all the time constants being identical within the experimental error of 
approximately + 10 %). This transient most likely corresponds to the decay of the triplet 
state. Furthermore, since all the bleaches completely recover (Figure 5.5) on this 3 us time 
scale, it can be concluded that no net chemistry is occurring for this analog. For hypericin 
and the hexamethoxy analog, there are at least two transients (the interpretation and 
determination of the time constants being more complicated because of the presence of 
overlapping bands). The shorter transient most likely corresponds to the decay of the triplet, 
103 
580nm 590nm 
600nm 605nm 
-2 6 14 22 30 -2 6 14 22 30 
Time (ps) 
Figure 5.4. Transient absorption traces (AA vs. time) of hypericin in acetonitrile, Xpump — 403 
nm. A global fit to the kinetics at the four probe wavelengths presented yields a time constant 
of 10 ps. 
while the longer corresponds to the presence of a photoproduct, which may be attributed to a 
radical or anion formed by H-atom or proton abstraction in the case of .hypericin (48). 
Finally, although oxygen is removed from all of the samples, the triplet decay of the 
compounds studied here occurs on a time scale of no longer than ~ 3 p.s. On the other hand, 
the triplet decay of thoroughly degassed hypericin is 1.1 ms at room temperature in ethanol 
(49). At least part of the reason for this discrepancy may be attributed to the high solute 
concentration required for the infrared measurements (see above), which contributes to self 
quenching by the ground state and to triplet-triplet annihilation. 
Figure 5.5. Comparison of the transient infrared spectra on the microsecond time scale of 
hypericin, O-hexamethoxy hypericin, and a hypericin analog that lacks carbonyl groups, the 
hexaacetoxy analog. The salient feature of the data is that the latter two compounds, which 
cannot execute excited state H-atom transfer owing to the absence of either labile protons or 
appropriate carbonyl groups, lack the feature at ~1450 cm."1. Ab initio calculations at the 
Hartree-Fock 3-21G level for the normal and two monotautomeric forms of the hypericin 
triplets indicate normal modes with substantial OeeeHeeeO character in the region —1400-
1460 cm"1. While these preliminary results do not demonstrate a time-resolved H-atom 
transfer, they do clearly point to a region of the spectrum that must be investigated in further 
studies. For hypericin and hexamethoxy hypericin (solid line, 0-1 ps; dashed line, 14-18 (is), 
for the reduced analog (solid line, 0-0.5 us; dashed line, 7-9 ps). 
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Table 5.1. Infrared Kinetics 
Band (cm-1) T (usee)* Initial Sign of Signal 
Hypericin 
1300-1332 9.1 Absorption 
1380-1414 2.9 Absorption 
1436-1464 3.3 Absorption 
1472-1492 5.9 Absorption 
1516-1536 12.5 Absorption 
1552-1584 3.0 Absorption 
1558-1628 5.6 Bleach 
Hexamethoxy Hypericin 
1232-1252 0.4 Bleach 
19.6 Bleach 
1260-1276 0.3 Absorption 
3.8 Absorption 
1280-1292 6.7 Bleach 
1300-1340 10.0 Absorption 
1360-1384 10.1 Bleach 
1516-1532 0.3 Absorption 
3.8 Absorption 
1536-1560 31.3 Bleach 
1564-1588 8.3 Absorption 
1612-1656 13.9 Bleach 
Hexaacetoxy Analog 
1204-1224 3.1 Bleach 
1304-1324 2.9 Absorption 
1348-1372 2.2 Absorption 
1556-1580 2.7 Absorption 
1596-1624 2.6 Bleach 
1636-1656 2.6 Absorption 
1748-1772 2.1 Absorption 
1780-1796 2.4 Bleach 
a The time constant indicates the relaxation time for the induced absorption or bleach and not 
a rise time for the appearance of the signal. Where two time constants are indicated, a 
biphasic relaxation was observed. Given the spectral bandwidth over which the kinetics were 
monitored, it cannot be determined with certainty whether the relaxation is itself biphasic or 
if two species with different time constants are observed. 
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The salientfeature of these spectra is in the region between 1400-1500 cm'1: a 
strong band is present here for hypericin and is absent in both O-hexamethoxy hypericin, 
which lacks hydrogen atoms that can coordinate to the carbonyl, and in the reduced analog 
which lacks the necessary carbonyls. The ground-state infrared spectrum of hypericin is 
included at the top of the Figure, Ab initio quantum mechanical calculations (Table 5.2) 
reveal strong normal modes in this spectral region for the triplet species of the normal form 
of hypericin and the 6, 14- and 7, 13-dioxo monotautomers (Figure 5.1). Calculations were 
not performed for the triplet species of the double tautomers (44). Assignments of these 
modes are given in Table 5.2. 
CONCLUSIONS 
A vibrational mode corresponding to H-atom translocation has been identified in 
hypericin by the joint contributions of synthetic, computational, and spectroscopic methods. 
Identification of this mode is a only a first step in providing a direct demonstration of 
excited-state intramolecular H-atom transfer in hypericin and its analogs. There is 
considerable work to be accomplished. As indicated in Table 5.2, ab initio calculations 
predict that the normal modes in this region of the spectrum are very close for the normal and 
monotautomeric forms. The direct observation of the formation of the tautomer will require 
both adequate temporal and spectral resolution. 
It must be remembered, furthermore, that the identification of the H-atom 
translocation mode is not equivalent to the identification of the reaction coordinate. We 
have attributed the absence of a deuterium isotope effect on the excited-state H-atom transfer 
(for the -10-ps component in hypericin and hypocrellin A) to the zero-point energy in the 
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Table 5.2. Calculated Frequencies of Normal Mode Vibrations of Hypericin Species 
7,14-dioxo tautomer, ground state singlet ("normal" form) 
frequency 
(cm1) 
scaled * oscillators) 
1238 1102 Ring breathing + C(13)-0 and C(l)-0 stretches. 
C(2>C(3>OH and C(5>C(4>OH motions. 
1331 1185 Ring breathing mode + Some C(l)-0 and C(6)-0 stretches. 
1377 1225 Ring breathing + out of phase 
C(13>0 and C(8>0 + out of phase C(1>0 and C(6>0 stretches. 
1489 1325 Ring breathing mode + out of phase C(13)-0 and C(8)-0 + out of phase 
C(1>0 and C(6>0 + C(13>0-H and C(8)-0-H stretches. 
1500 1335 Ring breathing mode + in phase C(l)-0 and C(13)-0 stretches. C-C=0 
(7,14) bending. H bonding affected 
1558 1387 Ring breathing mode + C(1>0 and C(6>0 in phase stretch + C(I3>0 
and C(8>0 in phase stretch. C(13)-0-H bend (small). 
1723 1533 C-C-O movements (8,13). O-H stretches (8,13) + C-O-H bending. 
H bonding affected. 
1746 1554 C-O-H movements (1, 13, 6,8). H bonding affected + mostly ring 
breathing. 
1811 1612 Ring motion + out of phase C(7)=0 and C(14)=0 stretches. C(1>0 
and C(13)-0 in phase stretches. H bonding affected. 
7,14-dioxo tautomer, lowest triplet ("normal" form) 
frequency 
(cm1) 
scaled * oscillators) 
1345 1197 Ring breathing motion + C-O stretches. 
1350 1201 C-O in phase stretch (1,6) + Ring breathing. 
1399 1245 Out of phase C-O stretch (8,13) + Smaller C=0 out of phase stretches. 
Ring motion. 
1424 1267 Ring breathing (C-C=0 backbone movements (7,14) ) 
C-O-H bends (1,13,6,8). H bonding affected. 
1459 1298 Ring motion. Out of Phase C=0 movements. In phase C-O (1,13) 
H bonding affected. 
1504 1339 Out of Phase C-O stretch (8,13) + ring motion. 
H bonding affected. Small C-O-H bending. 
1554 1384 In phase C-O stretch (1,6) + small C=0 stretches + Ring motion. 
H bonding affected 
1605 1428 Out of Phase C=0 stretch (7,14). Out of phase C-O stretch (1,6 and 
8,13). Ring motion. H bonding affected 
1707 1520 Small C-O-H movement (8,13). Ring motion. H bonding affected 
1712 1524 C-O-H (1,6,13,8). O-H bends. H bonding affected 
1727 1537 C-O-H bends (8,13). H bonding affected. 
1812 1613 C=0 out of phase stretch (7,14). O-H bends (1,6,8,13). 
H bonding affected strongly. 
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6,14 dioxo tautomer, lowest triplet (monotautomer) 
frequency 
(cm1) 
scaled 1 oscillators) 
1268 1128 Ring breathing + In phase C(13>0 and C(8>0 stretches. 
1273 1133 Ring breathing + 1 and 7 in-phase C-O stretches + 
13 and 8 out of phase C-O stretches. I, 8 and 13 C-O-H bends (small). 
(H bonding affected). 
1299 1156 Ring breathing +• C(1>0 stretch. C(1)-C(14>C(13) backbone breathing 
+ 13 C-O-H bending. 3 C-O stretch. 3 O-H bend. (H bonding affected). 
1388 1236 lO-H bending + 3 O-H bending + ring breathing. 
(H-bonding affected). 
1407 1252 Ring motion + In-phase 14 C=0 stretch and 7 C-O stretch. 8 C-O 
stretch. 1 and 8 O-H bending. (H-bonding affected). 
1529 1361 1 and 13 out of phase C-O stretches. 7,8 C-O-H bends. C(3)-0 stretch + 
ring motion. (H bonding affected). 
1545 1375 7,8 C-O in-phase stretches. 1 C-O stretch. 
7 O-H bending. Ring motion. (H bonding affected). 
1635 1455 8, 1, 13 O-H bends + ring breathing (C(9>C(10) stretch). 
1714 1525 C12-CI3 stretch + C(I3>0-H 
bend + C(14) = O out of plane motion + 13 O-H bend. (H bonding 
strongly affected). 
1747 1554 Out of phase C=0 stretches + C(13)-0 stretch. O-H bends (small) + 
ring breathing (H bonding affected). 
1816 1616 14 C=0 stretch. C(2>C(1>0 movement 1 and 13C-O-H bends. (H 
bonding affected). 
1829 1627 6 C=0 stretch. 7 and 8 C-O-H bends. ( H bonding affected). 
7,13 dioxo tautomer, lowest triplet (montautomer) 
frequency 
(cm1) scaled * oscillators) 
1268 1128 Ring breathing +• 1, 7 and 13 C-O stretches. 
1311 1166 Ring breathing. 
1393 1239 Ring motion. 7 C=0 out of plane stretch. 1, 8 C-O stretches. 
1413 1258 Ring breathing (mainly C(11)-C(12) stretch). 13, 14 C-O + C=0 stretch 
(In Phase). 7 C=0 stretch. 8,2 O-H bends (small). (H-bonding affected). 
1473 1311 1,6 out of phase C-O stretch. 8 C-O stretch. Ring breathing. 
1529 1361 7 C-O and 14 C=0 out of phase stretch. 6 and 8 out of phase C-O 
stretch. O-H bends. Ring motion. (H bonding affected). 
1568 1396 In phase 1 and 14 C-O stretch + Ring motion. 6, 14 C-O-H bends 
(small). (H-bonding affected) 
1653 1471 Ring motion. C(13)-0 stretch. C(l)-0-H bend. 
1729 1539 6 C-O-H movement. (H bonding affected). 
1809 1610 6,8, 14 O-H bends. 7 and 13 out of phase C=0 stretch. (H bonding 
affected) 
1820 1619 14, 1 O-H bends. 13 C=0 stretch. (H bonding affected). 
a The calculated frequencies are scaled by a factor of0.89 (52). 
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proton coordinate lying above the barrier, and the hydrogen atom being effectively 
delocaiized between the two oxygen atoms. Consequently, the reaction coordinate for the 
excited-state H-atom transfer cannot be identified with the proton coordinate and it must be 
concluded that other intramolecular motions are in fact responsible for the process. 
Temperature dependent measurements indicate that these motions are extremely low-
amplitude, Ea = 0.044 ± 0.008 kcal/mol for hypericin (20). Because the nature of this motion 
is not yet identified, we refer to it as the "skeleton coordinate " (24,50). We propose that it is 
the time-scale for this latter conformational change that determines the observed H-atom 
transfer time. The exact nature of the conformational changes that are coupled to the H-atom 
transfer reaction in hypericin and hypocrellin has yet to be identified (51). 
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CHAPTER 6: THE ROLE OF OXYGEN IN THE ANTIVIRAL 
ACTIVITY OF 
HYPERICIN AND HYPOCRELLIN 
A paper published in Photochemistry and Photobiology1 
Jaehun Park1, Doug S. English1, Yvonne Wanmemuehler2, Susan Carpenter*2, 
and Jacob W. Petrich*1 
ABSTRACT 
The light-induced antiviral activity of hypericin and hypocrellin in the presence and 
absence of oxygen was examined under experimental conditions where the effect of oxygen 
depletion could be quantified. There was a significant of reduction of light-induced antiviral 
activity of hypericin and hypocrellin under hypoxic conditions. Interestingly, antiviral 
activity of hypocrellin was not observed at low oxygen levels at which hypericin retained 
measurable virucidal activity. This suggests that additional pathways, such as the generation 
of protons from excited states of hypericin, may enhance the biological activity of activated 
oxygen species. 
INTRODUCTION 
The naturally occurring polycyclic quinones hypericin and hypocrellin are of current 
interest because of their light-induced (1) antiviral and- antitumor activity (2-11). In addition, 
^Reprinted with permission from. Photochemistry and photobiology, 1998,68, 593. 
^Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111. 
^Department of Microbiology, Immunology, and Preventive Medicine, Iowa State 
University, Ames, IA 50011-1250 
'Authors to whom correspondence should be addressed. 
119 
hypericin has attracted attention for its antidepressant activity (12-15). We have discussed 
elsewhere several aspects of the excited-state photophysics of hypocrellin and hypericin (16-
25) and have proposed means of exploiting these properties (26,27). These molecules have 
been the subject of several reviews (27-30). 
It has been shown that the antiviral and antitumor activities of hypericin can be 
dependent on oxygen (9,10). However, the mechanism of action of hypericin at the cellular 
level still remains unclear. Usually photosensitization processes involve molecules having a 
high triplet yield (31). The triplet state of a photosensitizer, such as hypericin, may induce 
two different kinds of common and well known photoreactions. The first and perhaps most 
common is the so-called Type n, oxygen-dependent, mechanism. Singlet oxygen formation 
occurs via energy transfer from the triplet state of the photosensitizer to the ground triplet 
state of molecular oxygen. The second is the Type I radical mechanism. This complex 
mechanism may involve any of several reactive species such as singlet oxygen, l02 (31,32), 
superoxide radical anion, 02*~ (33,34), hydroxyl radical, *OH (33,34), as well as hypericin 
radicals and radical ions (33). 
Comparative studies for nine perylenequinones, including hypocrellin and hypericin, 
provide evidence, however, that the quantum yield of singlet oxygen formation is not 
sufficient to explain the reported antiviral activities of these molecules, and that other 
structural features of perylenequinones are involved (36). In fact, the quantum yield of 
singlet oxygen from hypericin is much less than had initially been presumed. Recently, 
Jardon and coworkers have revised their earlier estimation of a singlet oxygen quantum yield 
of0.73 (32), essentially equal to the triplet yield, to 0.36 in ethanol and less than 0.02 in 
water (37). Based on this result, mechanisms involving only oxygen clearly cannot explain 
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all the activity of hypericin. 
We had previously reported that hypericin does not require oxygen for its antiviral 
activity (24,27,38,39). In those studies, however, we were not able to estimate accurately 
low oxygen levels in our virus samples. In the present study, we reexamine the importance 
of oxygen using experimental conditions where the effect of oxygen depletion could be 
quantified. The results indicate that while antiviral pathways independent of oxygen may 
exist, the role of oxygen in this activity is significant. The ability of photogenerated protons 
to enhance the activity of activated oxygen species (40) is considered to be of importance. 
MATERIALS AND METHODS 
A. Titration of infectious virus. Antiviral assays were done in low light conditions. 
Cell-free stocks of the MA-1 isolate of EIAV containing approximately 107 focus-forming 
units/ml (FFU/mL) of EIAV, were diluted 1:10 in phosphate-buffered saline (PBS). 
Hypericin or hypocrellin A (Molecular Probes) were added to a final concentration of 
10ng/ml, and samples were deoxygenated and/or illuminated as described below. Following 
treatment, serial ten-fold dilutions of samples were inoculated onto equine dermal cells in the 
presence of 8 jig/mL polybrene which is for increasing viral effectivity. Cells were 
incubated five days, fixed in ice cold methanol, and virus-infected cells were detected by 
immunocytochemistry as described elsewhere (1,41). Foci of infected cells were counted 
and results are expressed as logio reduction in virus titer as compared to an untreated control 
sample. 
B. Quantitaive measurement of oxygen levels. What is meant by "hypoxic" 
depends on the sensitivity and precision of the oxygen-detection technique. Under our 
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experimental conditions, it is unwieldy to control accurately the amount of oxygen dissolved 
in our samples before and after deoxygenation, which is necessary in order to know the 
lowest oxygen concentration that we can detect. We have chosen, therefore, an indirect 
measurement of oxygen levels, as a function of ATP concentration, in terms of the 
generation of chemiluminescence by the reaction of luciferase and luciferin. 
The ATP assay is based on the requirement for ATP in the production of 
chemiluminescent emission (emission maximum ~ 560nm at pH 7.8) (26,27). The reaction 
is pseudo first-order in ATP when all reactant concentrations except that of ATP are in 
excess. Similarly, under hypoxic conditions all reactant concentrations except that of oxygen 
are in excess; and the reaction is pseudo first-order in oxygen. Because the 
chemiluminescent reaction requires a one-to-one ratio of ATP to oxygen, all other things 
being equal, if the rate of chemiluminescent emission produced is the same for a reaction that 
is pseudo first-order in oxygen or ATP, we can assume that the concentrations of ATP and 
oxygen are the same in both reactions. 
To measure the limit of oxygen detection using the ATP assay, 1.8 mg/mL of 
luciferase-luciferin in glycine buffer (Sigma, L0633 ATP standard assay kit, 3 x 10"15M 
sensitivity) was prepared in PBS buffer. The chemiluminescent reaction was initiated by 
adding 5 |iL of ATP to 1 mL of the luciferase/luciferin solution. After the samples were 
injected with 5 fxL of ATP, chemiluminescence was monitored at 614 nm in a SPEX 
Fluoromax with the excitation beam blocked. The detection wavelength of 614 nm was 
chosen because here the chemiluminescence is not obscured by hypericin or hypocrellin 
absorption. A 1 -mm emission slitwidth, corresponding to a 4-nm bandpass, was employed. 
Chemiluminescence was collected from 500-750 nm with scan rate (integration time) of 0.3 
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sec/nm and is reported here in arbitrary units of counts per second (cps). 
C. Illumination and deoxygenation. Samples were prepared by adding an aliquot 
of hypericin or hypocrellin to a final concentration of 2.0 x 10*5 M and 1.8x10"5 M, 
respectively, to 1 mL of the EIAV containing 1.8 mg/mL of luciferase-luciferin in glycine 
buffer (Sigma, L0633 ATP standard assay kit, 3 x 10"I5M sensitivity). Preliminary 
experiments indicated these conditions had no background antiviral activity as compared to 
untreated controls (data not shown). Samples were deoxygenated with argon in glass vials 
fitted with rubber septa and kept on ice. Other methods of deoxygenation such as freeze-
pump-thaw cycles were prohibited because multiple cycles result in decreased virus 
inactivity. After stirring and/or deoxygenating, the samples were injected with 5 of 0.1 
M ATP and monitored for chemiluminescence as described above. In order to activate 
hypericin or hypocrellin, the samples were illuminated for 10 minutes, while stirring, with a 
300-W projector bulb fitted with a 530-nm long-pass filter. Following illumination, samples 
were kept on ice in the dark and assayed for infectious virus as described above. 
D. Singlet oxygen assays. Singlet oxygen assays were performed using a liquid 
nitrogen cooled CCD (North Coast model EO-817). A Q-switched Nd:YAG (Laser 
Photonics KYD300) was used for excitation producing 10 kHz 50 ns pulses. Fluorescence 
and scattered light were blocked using 1.3 pm bandpass filter fitted with a silicon slab to 
block wavelengths shorter than 960 nm. The excitation beam was chopped at 400 Hz and the 
output of the detector was fed to a lock-in amplifier (Stanford Research SR830). Two 
samples from the same solution were prepared for each experiment and each was stirred in a 
cuvette fitted with a septum for 20-25 minutes. One sample was kept under flowing argon 
and the other was kept under flowing oxygen. Unless otherwise indicated, 
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tetraphenylporphine (TPP) in benzene was used as the standard for the singlet oxygen yield, 
= 0.62 (42). To calculate the quantum yield of singlet oxygen, the method below was 
used. 
The background signal from a deoxygenated sample, Sdeox, was subtracted from the 
signal obtained from an oxygenated sample, Sox. 
csample o e OD (532 nm)ox 
s 
~~ 
sox — 5deox oD (532 nm)deox (1) 
The signal difference between oxygenated samples and deoxygenated samples was 
usually more than a factor of 10. The signal from the standard, TPP, was calculated in the 
same way and the quantum yield of the singlet oxygen sample was calculated, relative to that 
of TPP, as: 
gsampie OD (532 nm)^ 
^ s™ OD (532 nm)samp,e ^ 
Where the optical density, OD, is measured at the excitation wavelength of 532 nm. The 
measured <t> values reported in Table 6.1 are the average of four experiments. 
RESULTS AND DISCUSSION 
Previous studies in our laboratory had suggested that significant antiviral activity of 
hypericin could be observed in hypoxic conditions. In the present study, we reexamined the 
importance of oxygen using experimental conditions where the effect of oxygen depletion 
could be better quantified. The detection limit of the ATP assay was 8.50 x 10"7 M with 70 
cps (Figure 6.1). Based on our above argument, we conclude that the detection limit of 
oxygen is 8.50 x 10"7 M at 70 cps of chemiluminescence measured at 614 nm using a scan 
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Table 6.1. Quantum yield of singlet oxygen, O 
compound solvent Orel <D 
hypericin benzene 0.55 ± 0.07+ 0.34 ±0.05+ 
hypocrellin benzene 1.08 ±0.11+ 0.67 ±0.07+ 
hypocrellin ethanol 2.03 ± 0.33* 0.73 ±0.12* 
hexamethoxyhypericin* ethanol 3.04 ±0.27* 1.09 ±0.10* 
+TPP in benzene used as standard, O = 0.62 (42). 
^Hypericin in ethanol used as standard, O = 0.36 (37) 
"Prepared as described in English et al. (19). 
rate of 0.3 sec/nm. Our previous work used an oxygen detection kit that was only sensitive 
to levels of 6.25 x 10"6 M (38). With the more sensitive assay conditions employed here, 
samples contained under a normal atmosphere of air had typical levels of oxygen providing 
15,000-32,000 counts per second whereas samples which haH been stirred under a steady 
flow of argon for 20 minutes or more had typical levels of oxygen providing 280-7,000 
counts per second. 
The antiviral activity of hypericin and hypocrellin was markedly reduced by 
deoxygenation (Figure 6.2). Both hypericin and hypocrellin decreased infectious virus titers 
by more than 1,000 fold in the presence of oxygen and light. In low oxygen conditions, 
however, hypericin gave only a 10-fold reduction in virus titer and hypocrellin had no 
detectable antiviral activity. In fact, no antiviral activity of hypocrellin was detected at 
oxygen levels three to four times higher than that in which hypericin retained some 
measurable activity, indicating that deoxygenation had a much more drastic effect on 
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Figure 6.1. A log-log plot illustrating the effect of deoxygenation on the virucidal activity of 
hypericin and hypocrellin. Samples containing approximately 106 FFU were treated with 
hypericin or hypocrellin, deoxygenated by argon, and assayed for infectious virus as 
described in the text. Results are reported as logio reduction in virus titer in test samples as 
compared to an untreated control sample. Oxygen concentrations are quantified in terms of 
the chemiluminescent assay described in the text. 
hypocrellin-activity than on hypericin activity. This is of interest because the singlet oxygen 
yield of hypocrellin is roughly twice that of hypericin (Table 6.1). Together, these results 
suggest that hypericin and hypocrellin differ in the levels of oxygen required for optimal 
antiviral activity. We had previously taken these differences to indicate that oxygen was not 
necessary for antiviral activity in hypericin (39). The present results clearly demonstrate that 
oxygen plays a critical role in virus killing by both hypericin and hypocrellin; however, 
additional processes may contribute to the enhanced biological activity of hypericin at low 
oxygen levels. 
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Figure 6.2. Dependence of the chemiluminescence signal at 614 nm on ATP concentration. 
Each point represents data from a reaction that is pseudo first-order with respect to ATP. 
Because the stoichiometry for the chemiluminescent reaction is the same for ATP as for 
oxygen, the intensity of chemiluminescence, as measured in counts per second (cps) is taken 
as a quantitative measure of oxygen concentration under "hypoxic" conditions, when the 
reaction is expected to be pseudo first-order with respect to oxygen. See text for details. 
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A significant nonradiative process in hypericin and its analogs is intramolecular 
proton (or atom) transfer (16-25). Of special relevance to the role of labile protons for the 
light-induced biological activity of hypericin is the observation that hypericin acidifies its 
surroundings upon light absorption (40, 43,44). The role of photogenerated protons takes on 
significance in the context of the growing body of literature implicating changes in pH with 
inhibition of virus replication (45), antitumor activity (46,47), and apoptosis (48-51). 
Recently we have employed a confocal laser microspectrofluorometric analysis to 
monitor intracellular pH changes during photosensitization of cells by hypocrellin A using 
the ratiometric fluorescent pH probe, C-Snarf-1 (40). Under 0.1 ji.W of excitation power, this 
pH decrease is larger and faster for cells treated with hypocrellin A than for those treated 
with hypericin. Thus, hypocrellin appears to be more efficient than hypericin in producing 
photoinduced pH decreases. This interpretation is supported by the observation that the 
initial value of the pH is already very low when cells are not protected from ambient light 
before the microspectrofluorometric measurements. Such high sensitivity of hypericin to 
light is not observed. Because acidification occurs so rapidly with hypocrellin, it may be that 
the transferred protons do not effectively potentiate the activity of oxygen species. An 
example of such acid-induced potentiation is the following. It has been shown that while 
superoxide radical, 02*~, does not react with linoleic acid, its conjugate acid, the 
hydroperoxyl radical, H02e, does so at a biologically significant rate (52-54). 
CONCLUSIONS 
Hypericin is a more effective antiviral agent at low oxygen concentrations than is 
hypocrellin (Figure 6.2). Photogenerated protons from hypericin and hypocrellin 
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(39,40,43,44) are suggested to contribute to this antiviral activity. One possible mechanism 
by which these protons may enhance antiviral activity is by potentiation of activated oxygen 
species. The light-induced pH drop is more rapid for hypocrellin than for hypericin. 
Consequently, it is possible that for hypocrellin at low oxygen levels, under experimental 
conditions identical to those used for hypericin, the light-induced pH drop is too rapid to be 
effective in activating the oxygen species. It is, of course, possible that the enhanced antiviral 
activity in hypericin arises from direct interaction ofhypericin itself or reactive hypericin 
species in a classical type I mechanism. 
Our previous work has indicated that antiviral activity ofhypericin is dependent on 
the hypericin concentration (26). The present study has demonstrated the sensitivity of the 
antiviral activity ofhypericin and hypocrellin to the concentration of oxygen. A 
comprehensive investigation of the biological activities ofhypericin, hypocrellin, and their 
analogs will necessarily consider the roles of the photosensitizer concentration, the oxygen 
concentration, and the intensity and duration of the light exposure. 
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CHAPTER 7: TUMOR CELL TOXICITY OF HYPERICIN AND 
RELATED ANALOGS 
A paper submitted in Photochemistry and Photobiology 
Nick J. Wills1, Jaehun Park2, Jin Wen2, Sarathy Kesavan2, George A Kraus2, 
Jacob W. Petrich2, and Susan Carpenter1* 
ABSTRACT 
A series ofhypericin analogs were found to differ in their cytotoxic activity induced 
by ambient light levels. These analogs vary in their ability to partition into cells, to generate 
singlet oxygen as well as in other photophysical properties. The data suggest that the 
biological activity ofhypericin is due to a combination of factors whose roles may vary 
under different circumstances. 
INTRODUCTION 
Hypericin and pseudohypericin (Figure 7.1) are members of the phenanthroperylene 
quinone family and are major constituents of the plant Hypericum perforatum, commonly 
known as St. John's wort. Hypericin has demonstrated light-induced anti-tumor and antiviral 
(1-5) activities and has attracted interest as a possible treatment for various cancers and viral 
infections (3,4,6). While the biological activities ofhypericin have been well documented, 
the molecular and cellular events that mediate those activities are less well characterized. 
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Figure 7.1. Structure ofhypericin (1), pseudohypericin (2), and analogs 3-8. 
Light-induced production of singlet oxygen is thought to be the primary mechanism of tumor 
cell toxicity (7). Singlet oxygen production results in lipid peroxidation and membrane 
damage in the cell, leading to disruption of the cell membrane and a necrotic phenotype (8,9). 
Lower levels of singlet oxygen may lead to leakage of the mitochondrial membrane with 
subsequent release of cytochrome c and activation of a pro-apoptotic enzymatic cascade (8). 
Light activation ofhypericin can induce an intracellular pH drop (10), and it has been 
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suggested that intermolecular proton transfer contributes to the antiviral and cytotoxic effects 
of hypericin-related compounds, even in relatively hypoxic conditions (11). In addition, 
hypericin interferes with cellular transcription factors and a number of cell signaling 
pathways (12-15). Although it is not known how interactions with cell signaling pathways 
contribute to hypericin-mediated cytotoxicity, inhibition of these pathways may be an 
important component of any therapeutic application of hypericin-related compounds. 
Hypericin is a more effective antiviral agent than pseudohypericin (16,17); however, 
the molecular basis for the differences in activity is not well understood. Insight into the 
molecular rationale for the differences in biological activity among related hypericin analogs 
may enable researchers to design more effective therapeutics. Previous studies from our 
group showed that minor changes in substituents resulted in dramatic differences in antiviral 
activity (18,19). In this paper, we extend our previous analyses ofhypericin analogs to 
examine their level and mode of cytotoxic activity. These studies suggest that cytotoxic 
activity depends on a combination of factors, including photophysical properties, membrane 
solubility, and singlet oxygen production. 
MATERIALS AND METHODS 
Cell lines. The human colon adenocarcinoma cell line SW480 (ATCC# CCL 228) 
was grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal 
calf serum and penicillin/streptomycin. The cells were incubated at 37°C with 7% CO%. 
Synthesis of analogs. Hypericin (Molecular Probes, Eugene, OR) and 
pseudohypericin (Calbiochem, La Jolla, CA) were purchased from commercial sources. The 
synthesis of analogs 3-6 was previously described (18,19). To synthesize the methyl ether 
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of pseudohypericin (7) a catalytic amount of sulfuric acid was added to a solution of 10 mg 
of pseudohypericin in 2 mL of methanol. This solution was stirred at ambient temperature 
for four hours and heated at 45 °C for four hours. The solution was then cooled, 
concentrated in vacuo and the product purified using a silica gel preparative layer plate. The 
benzoate of pseudohypericin (8) was synthesized by adding N-methy Imorpho line (5 mg, 
0.049 mmol) to a solution of benzoic acid (0.0214 mmol) in anhydrous methylene chloride (2 
mL) at —15 °C. The solution was stirred for 5 minutes at this temperature, after which 
benzylchloroformate (8 mg, 0.046 mmol) was added to get a yellow solution. The yellow 
solution was stirred at —15 °C for 15 minutes before 1 -hydroxybenzotriazole (3 mg, 0.022 
mmol) was added. The reaction mixture was stirred for an additional 20 minutes before 
pseudohypericin (11 mg, 0.0213 mmol) dissolved in DMF (0.2 mL) was added, resulting in a 
deep red solution. The solution was allowed to warm to room temperature and was stirred at 
room temperature for an additional 12 h. After 12 h, the solvent was evaporated and the 
crude mixture was purified by preparative thin layer chromatography using a mixture of ethyl 
acetate and methanol. The steady state absorption and emission spectra of all analogs are 
given in Figure 7.2. 
Cytotoxicity assay. SW480 cells were seeded in 6-well plates at a concentration of 
lxlO6 cells/well, and allowed to adhere overnight. The next day, the media was replaced 
with prewarmed media, and hypericin or related analogs were added to a final concentration 
of 20 |iM. Cells were incubated at room temperature for 30 minutes in the dark, or were 
illuminated under standard overhead fluorescent bulbs (Philips, 34W) at a distance of 1.8 m 
from the light source. Cell viability was assayed using the MTT metabolic activity assay 
(R&D Systems, Minneapolis, MN), and the percent cytotoxicity was calculated from a 
Figure 7.2. Steady-state absorption (black line) and emission (gray line) of hypericin and 
analogs. Absorption measurements were obtained with a Perkin Elmer LamdalS double 
beam UV-Vis spectrophotometer with 1-nm band pass. A 1-cm pathlength cuvette was 
employed. Fluorescence measurements are obtained with a Spex Fluoromax fluorometer. 
The individual spectra (indicated by analog number) are normalized to the peak of maximum 
absorbance in the visible range. The extinction coefficients shown in Table 7.1 are: 1, 
44,000 M"1 cm"1 ± 5% at 599nm; 2, 9,000 MT1 cm-1 ± 10% at 599nm; 3, 21,000 MT1 cm-1 ± 
10% at 612nm; 4, 23,000 M-1 cm'1 ± 10% at 596mm 5, 6,000 NT1 cm'1 ± >50% at 594nm; 6, 
8,100 M"1 cm"1 ± 50% at 528nm; 7, 640 MT1 cm*1 ± 20% at 600nm; 8,450 MT1 cm"1 ± 15% at 
585nm. Extinction coefficients were determined as usual by plotting absorbance against 
concentration and taking the slope. Errors in extinction coefficient arise from uncertainty in 
the initial concentration of stock solution, owing to solubility problems or perhaps to sample 
degradation over time. 
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standard curve derived from serial dilutions of known cell numbers. Each analog was 
assayed in triplicate, and each experiment was repeated at least two times. 
Cell Association. SW480 cells were aliquoted in a standard Eppendorf tube at 5 x 
105 cells in 500 p.1 phosphate buffered saline (PBS) containing 20 [jM of each analog. The 
tubes were gently rocked for 30 min in the dark, and the cells were pelleted by centrifugation. 
The supernatant fraction was collected (Fsup), the cells were extracted with 95% ethanol 
(Fext) as previously reported (3). To determine the amount of analog in each fraction, 30 pi 
of the undiluted analog (Fstart), Fsup, or Fext were added to 1.5ml DMSO and the steady 
state absorbance spectrum of the samples was measured using a Perkin Elmer LamdalS 
double beam UV-Vis spectrophotometer with 1 nm band pass. The absorbance readings 
were collected at the wavelength of peak visible absorption for each analog and were used to 
calculate the amount of analog that was cell associated as follows. The percent recovered (R) 
was calculated as: R = (AFext + AFsup)/AFsmrt* 100; the percent of the compound that was cell 
associated was determined as: CA=A^eM/ (Apext4" Afsup)* 100. For comparisons among the 
analogs, the percent cell-associated was corrected for the percent recovered as: Corrected 
Cell Associated = (CA/R)*100. All assays were done in duplicate and repeated two to three 
times. 
Measurement of Singlet Oxygen Yield. A 1-kHz Nd: YAG (Quantronix) was used 
to excite samples at 527 nm. The excitation irradiance at most of the samples was 13 
mW/cm2, except for 6, where it was 5mW/cm2. A laser pointer (B & W Tex Inc., Newark, 
DE) was initially tried as an excitation source, but its lower power, providing 2mW/cm2 at 
532nm, was insufficient to produce measurable quantities of singlet oxygen under the 
conditions of our experiment. Fluorescence and scattered light were blocked by a 1270 ± 40 
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nm bandpass filter fastened to a liquid nitrogen cooled charge-coupled device (North Coast 
model EO-817). The excitation beam was chopped at 400 Hz and the output of the detector 
was fed to a lock-in amplifier (Stanford Research SR510), which provided the signal, S, 
proportional to the intensity of the singlet oxygen luminescence. Rose bengal in DMSO was 
used as the standard for the singlet oxygen yield, <X>=0.162 (20). All analogs were measured 
in DMSO. The relative quantum yield and the quantum yield of singlet oxygen were 
calculated as below: where the optical density, OD, was measured at the excitation 
wavelength of527nm. 
d> = 0> x 0.162 Ssunple OD^f8"1 
r
"* /f\ 527nm 
oD%: 
(J) = 
rel g standard 
The OD of most of the compounds was —0.2, except for analogs 7 and 8, for which it was 
-0.08. The measured O values reported in Table 7.1 represent the average of three 
experiments. 
RESULTS 
Cytotoxic activity of hypericin analogs 
Previous studies had determined that hypericin analogs with minor alterations in 
substituents showed dramatic differences in antiviral activity (18). Initial experiments were 
done to determine if these analogs also differed in cytotoxic activity. SW480 cells were 
treated with 20 |jM of each analog and cytotoxic activity was quantified using an MTT assay 
(Figure 7.3). The cytotoxicity of hypericin (1) approached 100%, and exceeded the 
maximum sensitivity of the assay, which was determined to be 94% (data not shown). 
Pseudohypericin (2) and the other analogs displayed a range of cytotoxic activity in the light, 
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Table 7.1. Biological and photophysical properties of hypericin (1), pseudohypericin (2), and 
analogs 3-8. 
Cytotoxic! Cell Association2 1Oz Yield3'4 6 (M~1cm~1)5 
ty1 
Analog Recovered Cell Corrected 
Associated Cell 
Associated 
l 9 4 ±  2  9 6 . 2  6 7 . 9  7 0 . 5  0 . 3 4 ± 0 . 0 4  4 4 , 0 0 0  
2 21+16 9 3 . 3  6 5 . 2  7 0 . 0  0 . 4 6 + 0 . 0 2  9 , 0 0 0  
3 0 +  4  8 1 . 5  2 3 . 8  2 9 . 2  0 . 4 1 + 0 . 0 4  2 1 , 0 0 0  
4 37± 3 7 3 . 5  5 0 . 5  6 8 . 5  0 . 1 5 + 0 . 0 1  2 3 , 0 0 0  
5 8 8 +  5  1 1 7 . 0  7 2 . 6  6 2 . 1  0 . 2 5 ± 0 . 0 1  6 , 0 0 0  
6 19±12 5 5 . 0  1 4 . 8  2 6 . 8  0 . 2 1 + 0 . 0 2  8 , 1 0 0  
7 0±15 1 7 2 . 4  1 3 5 . 8  7 8 . 7  0 . 5 6 ± 0 . 0 3  6 4 0  
8 0 +  8  1 0 0 . 0  6 4 . 7  6 4 . 7  0 . 7  6 ± 0 . 1 1  4 5 0  
'Cytotoxicity determined by MTT assay and reported as percentages. 
2All values were calculated as described in Materials and Methods and are reported as 
percentages. 
3 As determined in DMSO, relative to rose bengal in DMSO used as standard. 0 = 0.162. 
4An extensive compilation of singlet oxygen yields is given in (20). 
^Wavelengths used for calculations and standard errors of mean values are given in the 
legend to Figure 7.2. 
whereas no compound tested had activity in the absence of light. The biological activity of 
hypericin analogs 3-6 was highly sensitive to changes in the number of hydroxyl groups on 
the phenanthroperylene ring. Analog 3, which was substituted with eight hydroxyl groups, 
showed no cytotoxic activity. Increased cytotoxic activity was observed when the bay 
hydroxyl groups (that is, those not involved in intramolecular hydrogen bonding with the 
carbonyl groups) were converted into methoxy groups (compare the relative activity of 
analogs 3, 4 and 5), with the cytotoxicity of 5 nearly that of hypericin. However, analog 6, 
where all of the hydroxyl groups were converted into methoxy groups, showed markedly 
reduced cytotoxic activity. This result is consistent with the hypothesis that the biological 
activity involves light induced acidification mediated by labile proton transfer (21). 
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Figure 7.3. Cytotoxic activity of hypericin (1), pseudohypericin (2), and analogs 3-8 on 
SW480 cells. Hashed bars represent experiments done in light, black bars represent 
experiments done in dark. The percent cytotoxicity was calculated relative to the number of 
viable cells in samples treated with DMSO alone. Values are the mean of at least four 
independent treatments, each assayed in triplicate. Error bars represent the standard 
deviation 
Pseudohypericin (2) consistently showed lower levels of cytotoxicity as compared to 
hypericin. In the majority of assays, pseudohypericin killed approximately 30% of the cells, 
although activity ranged from 0 to 50% across all experiments. Analogs 7 and 8, which 
contained additional modifications to the methanol side group, showed no cytotoxic activity. 
Overall, the analogs displayed similar patterns of tumor cell cytotoxicity as was previously 
reported for their antiviral activity (18), suggesting a similar mechanism may be involved for 
the antiviral and anti-tumor activity of hypericin and related analogs. 
146 
Cell association studies 
The cytotoxic activity of the hypericin analogs is likely dependent on the amount of 
analog that associates with the cell. Therefore, we calculated the amount of each analog that 
partitioned with SW480 cells after a 30 minute incubation at room temperature in the dark. 
Following incubation, cells were centrifoged and the amount of analog in the supernatant and 
the cell extract fractions was calculated based upon their absorbance. In most cases, using 
the corrected cell association values, 62-70% of each analog partitioned with the cell 
fraction. The exceptions were analogs 3 and 6, where less than 30% of the analog was cell 
associated. The cytotoxicity of 3 and 6 was significantly less than that of hypericin, 
suggesting that the reduced level of cell association may contribute to the reduced 
cytotoxicity of these analogs. However, there was a range of cytotoxic activity among the 
analogs with similar values of cell association. When all analogs were considered, there was 
no correlation between cell association and cytotoxic activity (Figure 7.4a). Therefore, 
partitioning of the molecule into the cell may be necessary for the cytotoxic activity of the 
analog, but this factor alone is not sufficient to explain all of the differences seen in cytotoxic 
activity. 
Singlet oxygen generation 
Singlet oxygen is considered to be important in cytotoxic activity of photoactivated 
hypericin, and we measured the singlet oxygen yield for analogs 1-8 (Table 7.1). Among 
the analogs in our study, we found some with high singlet oxygen yields and low cytotoxic 
activity, whereas other analogs showed lower singlet oxygen yields and high cytotoxic 
activity. 
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Figure 7.4. Correlation between cytotoxic activity and a) corrected cell association or b) 
singlet oxygen yield. The location of each analog is indicated by 1-8. The R2 value was 
calculated by linear regression analysis using Microsoft Excel. 
Notably, 7 and 8, which have the highest yields, were essentially non-toxic to the SW480 
cells under ambient light conditions. Also, 5 had lower singlet oxygen yields and higher 
cytotoxic activity than 2, yet both showed comparable cell association levels. Overall, we found 
a very poor correlation between cytotoxicity and singlet oxygen yield (Figure 7.4b). 
The singlet oxygen yields were, by necessity (see Materials and Methods), measured 
using a high intensity excitation source. In contrast the light-induced cytotoxicity of the analogs 
was measured using fluorescent room light. Therefore, we included the maximum extinction 
coefficients of all compounds in our comparative analysis (Table 7.1). The maximum extinction 
coefficients of 7 and 8 in the visible region of the spectrum were on the order of 100 times less 
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than that of hypericin; those of analogs 2, 5 and 6 were approximately 5 fold lower than 
hypericin. These differences in absorbance may provide a partial explanation for the low 
cytotoxicity of 7 and 8 in ambient light conditions, despite efficient singlet oxygen production 
under high intensity excitation. However, comparative analysis within sub-groups of analogs 
having relatively similar extinction coefficients (Le. 1,3,4 or 2, 5,6), or singlet oxygen yields (2 
and 3), failed to find a correlation between either of these parameters and cytotoxicity. These 
results indicate that the photophysical properties of the analogs are an important component of 
cytotoxicity, but cannot account for all of the observed differences in cytotoxic activity shown in 
Figure 7.3. 
DISCUSSION 
Hypericin exhibits potent and diverse biological activities and has received wide 
attention as a potential therapeutic drug. However, the molecular mechanisms of bio logical 
activity are not well understood. We previously suggested that differences in the antiviral 
activity among hypericin and several synthetic analogs were due to differences in the ability 
of the molecules to partition between water and the cell membrane (18,19). Here, we used 
tumor cell toxicity to examine the importance of membrane association and photophysical 
properties to the cytotoxic activity of hypericin and related analogs. The analogs differed in 
their ability to partition into cells, to generate singlet oxygen, and in their maximum 
extinction coefficient. Each of these parameters was suggested to contribute to the biological 
activity of the analogs; however, no one parameter was found to correlate directly with 
cytotoxic activity. Optimal biological activity of photoactivated hypericin may therefore 
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depend on the interaction of a number of factors. Moreover, the relative contribution of each 
factor may vary, depending on the experimental conditions. 
It is not clear how minor modifications to hypericin side groups can result in dramatic 
differences in biological activity. Benzylic substituents exert an inductive (electron-
withdrawing) effect based on the electronegativity of the substituent. Such an effect 
influences the reactivity of the quinone. Wegner and co-workers (22) have shown that the 
greater the inductive effect of the benzylic substituent, the easier the quinone is to reduce. 
Once the quinone is reduced, the corresponding hydroquinone is harder to oxidize. If the 
biological activity of a bioactive quinone depends on the rate of regeneration of the quinone 
by in vivo oxidizing agents, a significant inductive effect will reduce activity. This is seen 
where the inductive effect of benzylic substituents (OBz > OH >H) inversely paralleled the 
cytotoxicity of the analogs (8 < 2 < 1). Further studies of hypericin analogs with benzylic 
substituents of lower electronegativity will be conducted to better understand this effect. 
Studies comparing hypericin analogs that differ in inductive effect may provide useful insight 
into the mechanism of hypericin cytotoxicity and will influence the design of "tethered 
molecules" composed of hypericin and bioactive molecules (19). A caveat in assessing these 
effects is to take into account the significance of the inductive effect on the absorption 
spectrum of the analogs: the seemingly innocuous presence of the -OH group in 2 
diminishes the maximum extinction coefficient by nearly a factor of 5 with respect to that of 
hypericin. This effect is even more pronounced in analogs 7 and 8, where it is reduced by 
nearly a factor of 100. 
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CONCLUSIONS 
For eight compounds, we have measured their cytotoxicity under ambient light 
conditions, their capacity to associate with SW480 tumor cells, and their singlet oxygen 
yield. There is no clear correlation among these three parameters, indicating that other 
factors are likely to be important for biological activity. More work is required to better 
understand the relationships among the parameters tested here, as well as those of incident 
light intensity and of photophysical properties such as light-induced pKa changes and redox 
chemistry. Other factors, such as interactions with specific subcellular organelles or cell 
signaling pathways, may also play a significant role in hypericin mediated cytotoxicity. The 
results presented here highlight the need for additional studies to eludicate the mechanisms of 
hypericin cytotoxicity. 
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CHAPTER 8. CONCLUSIONS 
The preceding chapters have shown the excited state photophysics of hypericin 
(chapter 3,4, 5) and light induced biological activity of hypericin and its analogs (Chapter 6, 
7). Femtosecond laser technology has provided the opportunity to investigate the rapid 
dynamics of these molecules. Our previous studies [1-6] suggested some evidence for the 
excited state H-atom transfer in hypericin. However, hypericin analog which has no labile 
protons does not show stimulated emission, which means no excited state H-atom transfer. 
Chapter 3 gives more clear evidence for the excited state H-atom transfer. 
Fluorescence upconversion measurements, which monitor only emission from the fluorescent 
singlet state, demonstrate that hexamethoxy hypericin, which possesses no labile protons, has 
an instantaneous rise time for its transient response. On the other hand, hypericin shows a 
clear 10-ps rise time. This confirms excited-state H-atom transfer as the primary 
photophysical process in hypericin. More direct demonstration of an excited state H-atom 
transfer can be done by observing the bleaching of the carbonyl or hydroxyl stretching 
frequency directly as a function of time following the laser excitation. A tunable infrared 
probe pulse with a visible or ultraviolet pump light source is required for this experiment. 
Ab initio calculations [7] and NMR experiments [8] suggest only one hypericin 
species, the normal form, is populated in the ground state. Since the NMR time scale might 
be slower than interconverting ground species, work should be done with higher time 
resolution and a tunable excitation source to reveal ground state heterogeneity. 
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In Chapter 4, a femtosecond transient absorption spectroscopy technique is used to 
determine if excited state H-atom transfer is concerted. Previous studies using human serum 
albumin (HS A) and hypericin [9] suggested that excited state H-atom transfer is concerted, 
but the results from the hypericin in reverse micelles show no evidence for a concerted 
hydrogen atom transfer mechanism. We are, however, unable to conclude if only one 
hydrogen atom is transferred or if two are transferred in a stepwise fashion 
In Chapter 5, by means of time-resolved infrared spectroscopy, ab initio quantum 
mechanical calculations, and synthetic organic chemistry, a region in the infrared spectrum, 
between 1400 and 1500 cm"1, of triplet hypericin has been found corresponding to 
translocation of the hydrogen atom between the enol and the keto oxygens, OeeHeeeO. This 
result is discussed in the context of the photophysics of hypericin and of eventual 
measurements to observe directly the excited-state H-atom transfer. 
In Chapter 6, light induced antiviral activity of hypericin and hypocrellin is compared 
in normoxic and hypoxic conditions. Although both molecules require oxygen to show full 
virucidal effects, hypericin is still effective at low oxygen level where hypocrellin is not. 
Since the singlet oxygen yield of hypericin is about half of that of hypocrellin, this result can 
not be explained by traditional Type II mechanism. We propose that the ejected proton upon 
illumination might enhance the activity of activated oxygen species. 
In Chapter 7, a series of hypericin analogs were found to differ in their cytotoxic 
activity induced by ambient light levels. These analogs vary in their ability to partition into 
cells, to generate singlet oxygen as well as in other photophysical properties. The percent 
distribution of hypericin and its analogs in cells are measured using a steady state absorption 
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technique. We attempt to find a relationship between those results and the exact localization 
of the drug at subcellular level 
REFERENCES 
1. Gai, F., M. J. Fehr and J. W. Petrich/. Am. Chem. Soc. US, 3384 (1993) 
2. Gai, F, M. J. Fehr and J. W. Petrich J Phys. Chem., 98, 8352 (1994) 
3. Gai, F, M. J. Fehr and J. W. Petrich J. Phys. Chem. 98, 5784 (1994) 
4. Fehr, M. J., M. A McCloskey and J. W. Petrich. J. Am. Chem. Soc. 117, 1833 (1995) 
5. English, D. S., W Zhang, G. A. Kraus and J. W. Petrich J. Am. Chem. Soc. 119, 2980 
(1997) 
6. English, D. S.; K. Das, J. M. Zenner, W. Zhang, G. A. Kraus, R. C Larock and J. W. 
Petrich J. Phys. Chem. A, 101,3235 (1997) 
7. Petrich, J. W„ M. S. Gordon, M. Cagle J. Phys. Chem. A, 102, 1647 (1998) 
8. Smimov, A. V., D. B. Fulton, A. Andreotti and J. W. Petrich J. Am. Chem. Soc. 121, 
7979 (1999) 
9. Das, K., A. V. Smimov, J. Wen, P. Miskovsky, and J. W. Petrich Photochem. PhotobioL, 
69, 633.(1999) 
